
The human oral microbiome can affect brain functions directly through the trigeminal nerve and olfactory system and indirectly via the oral–gut–brain axis. However, the potential link between the oral microbiome and mental health remains an area that requires further investigation. Taking into consideration that gut microbiota dysbiosis plays a role in the onset and progression of several mental disorders, as well as the potential influence of the oral microbiome on mental health via direct pathways, the present narrative review explores the role of the human oral microbiome in health and disease, along with the factors that affect its composition, with a particular focus on its potential impact on mental health, including its involvement in a range of mental disorders and brain-related conditions, such as Alzheimer's disease, Parkinson's disease, autism spectrum disorder, anxiety, depression, stress, bipolar disorder, Down's syndrome, cerebral palsy, epilepsy, and schizophrenia. Chronic oral diseases can impair the oral mucosal barrier, allowing microorganisms and endotoxins to enter the bloodstream, triggering systemic inflammation, and affecting the blood–brain barrier. This pathway can lead to neuroinflammation and cognitive dysfunction and contribute to adverse mental health effects. Additionally, translocation of oral bacteria to the gut can drive persistent inflammation and thereby affect brain health. Multiple studies suggest a potential relationship between the oral microbiome and several mental disorders, but further research is needed to strengthen the evidence surrounding these associations and to fully clarify the underlying mechanisms linking the oral microbiome to these conditions. Given the promising implications, future research should focus on elucidating the biological mechanisms through which alterations in the oral microbiome influence the development and progression of determinate neurodegenerative and neuropsychiatric disorders. Additionally, identifying reliable biomarkers linked to the oral microbiome could enhance early detection, diagnosis, and monitoring of these conditions.
Citation: Alejandro Borrego-Ruiz, Juan J. Borrego. Human oral microbiome and its influence on mental health and brain disorders[J]. AIMS Microbiology, 2025, 11(2): 242-294. doi: 10.3934/microbiol.2025013
[1] | Neetu Sharma, Sonu Bhatia, Abhinashi Singh Sodhi, Navneet Batra . Oral microbiome and health. AIMS Microbiology, 2018, 4(1): 42-66. doi: 10.3934/microbiol.2018.1.42 |
[2] | Davide Gerardi, Sara Bernardi, Angelo Bruni, Giovanni Falisi, Gianluca Botticelli . Characterization and morphological methods for oral biofilm visualization: where are we nowadays?. AIMS Microbiology, 2024, 10(2): 391-414. doi: 10.3934/microbiol.2024020 |
[3] | Paola Brun . The profiles of dysbiotic microbial communities. AIMS Microbiology, 2019, 5(1): 87-101. doi: 10.3934/microbiol.2019.1.87 |
[4] | Kerri Glassner, Eamonn MM Quigley, Lissa Franco, David W Victor III . Autoimmune liver disease and the enteric microbiome. AIMS Microbiology, 2018, 4(2): 334-346. doi: 10.3934/microbiol.2018.2.334 |
[5] | Stephen H. Kasper, Ryan Hart, Magnus Bergkvist, Rabi A. Musah, Nathaniel C. Cady . Zein nanocapsules as a tool for surface passivation, drug delivery and biofilm prevention. AIMS Microbiology, 2016, 2(4): 422-433. doi: 10.3934/microbiol.2016.4.422 |
[6] | Jane Tang . Microbiome in the urinary system—a review. AIMS Microbiology, 2017, 3(2): 143-154. doi: 10.3934/microbiol.2017.2.143 |
[7] | Mehdi Fatahi-Bafghi . Rat-Bite Fever due to the genus Streptobacillus. AIMS Microbiology, 2024, 10(4): 917-943. doi: 10.3934/microbiol.2024040 |
[8] | T. Amrouche, M. L. Chikindas . Probiotics for immunomodulation in prevention against respiratory viral infections with special emphasis on COVID-19. AIMS Microbiology, 2022, 8(3): 338-356. doi: 10.3934/microbiol.2022024 |
[9] | George L. Mendz, Nadeem O. Kaakoush, Julie A. Quinlivan . New techniques to characterise the vaginal microbiome in pregnancy. AIMS Microbiology, 2016, 2(1): 55-68. doi: 10.3934/microbiol.2016.1.55 |
[10] | Tjokorda Istri Pramitasuri, Ni Made Susilawathi, Ni Made Adi Tarini, AA Raka Sudewi, Matthew C Evans . Cholesterol dependent cytolysins and the brain: Revealing a potential therapeutic avenue for bacterial meningitis. AIMS Microbiology, 2023, 9(4): 647-667. doi: 10.3934/microbiol.2023033 |
The human oral microbiome can affect brain functions directly through the trigeminal nerve and olfactory system and indirectly via the oral–gut–brain axis. However, the potential link between the oral microbiome and mental health remains an area that requires further investigation. Taking into consideration that gut microbiota dysbiosis plays a role in the onset and progression of several mental disorders, as well as the potential influence of the oral microbiome on mental health via direct pathways, the present narrative review explores the role of the human oral microbiome in health and disease, along with the factors that affect its composition, with a particular focus on its potential impact on mental health, including its involvement in a range of mental disorders and brain-related conditions, such as Alzheimer's disease, Parkinson's disease, autism spectrum disorder, anxiety, depression, stress, bipolar disorder, Down's syndrome, cerebral palsy, epilepsy, and schizophrenia. Chronic oral diseases can impair the oral mucosal barrier, allowing microorganisms and endotoxins to enter the bloodstream, triggering systemic inflammation, and affecting the blood–brain barrier. This pathway can lead to neuroinflammation and cognitive dysfunction and contribute to adverse mental health effects. Additionally, translocation of oral bacteria to the gut can drive persistent inflammation and thereby affect brain health. Multiple studies suggest a potential relationship between the oral microbiome and several mental disorders, but further research is needed to strengthen the evidence surrounding these associations and to fully clarify the underlying mechanisms linking the oral microbiome to these conditions. Given the promising implications, future research should focus on elucidating the biological mechanisms through which alterations in the oral microbiome influence the development and progression of determinate neurodegenerative and neuropsychiatric disorders. Additionally, identifying reliable biomarkers linked to the oral microbiome could enhance early detection, diagnosis, and monitoring of these conditions.
The human mouth presents a range of substrates, including cheeks, gums, teeth, and tongue, which possess differences in chemistry, stability, and topography, providing distinct habitats for microbial communities [1]. A broad variety of microorganisms that colonize the oral cavity engage in complex interactions among themselves and with their host, typically resulting in a balanced coexistence, which is known as a state of eubiosis. Nevertheless, diverse factors such as dietary patterns, inadequate oral hygiene, tobacco use, and the effect of specific medications can disturb this fragile homeostatic balance, which is known as dysbiosis, potentially contributing to the onset of oral diseases and increasing the risk of systemic conditions, including mental health disorders [2]–[5].
Host-related factors can favorably influence the oral microbiome (OM), fostering diversity and equilibrium among distinct microbial species, which leads to a state of symbiosis and lack of disease [6]. Moreover, the human OM impacts a wide range of pivotal host functions, mediating a range of immunological, metabolic, and physiological processes, such as the maturation of the adaptive and innate immune system in the host [7].
Current research indicates that co-evolution has led to the functional integration of the host and OM, a relationship that underpins the concepts of holobiont or superorganism, highlighting that we function as a unified biological entity [8]. In this regard, the host gains advantages such as resistance to infection, achieved through the inhibition of colonization by pathogenic microorganisms [9], maturation of the adaptive and innate immune systems, and adjustment of immune response patterns to maintain a balance between anti-inflammatory and pro-inflammatory dynamics [10],[11]. Nevertheless, it is plausible that many of these advantages also extend to OM [12].
Following the achievements of the Human Microbiome Project [13] and the Human Oral Microbiome Database (eHOMD) [14], studies in oral microbiology have advanced to a new stage, with more than 2000 reference genomes of oral microorganisms currently compiled in the database [15]. This data has been leveraged to investigate the functions and varieties of microorganisms within the oral cavity, construct a chart of the oral microbiota distribution, and evaluate the composition of each microorganism [16]. However, despite these advancements, the potential link between OM and mental health remains an area that requires further investigation. For this reason, the present narrative review explores the role of the human OM in health and disease, along with the factors that affect its composition, with a particular focus on its potential impact on mental health, including its involvement in a range of mental disorders and brain-related conditions, such as Alzheimer's disease, Parkinson's disease, autism spectrum disorder, anxiety, depression, stress, bipolar disorder, Down's syndrome, cerebral palsy, epilepsy, and schizophrenia.
The oral environment is a diverse and conducive ecosystem for the proliferation of several microbial groups due to its adequate temperature, humidity, and nutrients provided by the gingival crevicular fluid and salivary proteins [6],[17]. OM consists of approximately 1000 bacterial species, although viruses, fungi, protozoa, and archaea are also present in smaller proportions [18]. The major bacterial phyla in the oral cavity include members of Actinomycetota, Bacteroidota, Fusobacteriota, Bacillota, Pseudomonadota, and Spirochaetota [15]. Interestingly, there are also other minority phyla and candidate phyla such as Chloroflexota, Chlorobiota, candidate phylum Gracilibacteria (GN02/BD1-5), Synergistota, candidate phylum SR1, candidate phylum radiation Saccharibacteria (TM7), and candidate phylum WPS-2 [19]–[22].
Although oral archaea are regarded as non-pathogenic, some of them have been described in several oral diseases, including periodontitis and caries [23],[24], belonging to the species Methanobrevibacter oralis, M. cuticularis, M. filiformi, M. ruminantium, and M. arboriphilius [25]. The oral mycobiome includes the genera Aspergillus, Aureobasidium, Candida, Cladosporium, Cryptococcus, Fusarium, Gibberella, Malassezia, Penicillium, Rhodotorula, Saccharomyces, and Schizophyllum, which have been primarily isolated from the oral rinses, supragingival plaque, hard palate, and saliva [26],[27]. The oral virome is composed of bacteriophages and eukaryotic viruses [28]. Most of the eukaryotic viruses found in the oral cavity are linked to various diseases, such as papilloma, condyloma, and focal epithelial hyperplasia caused by the human papillomavirus (HPV) infection [29],[30]; herpes genitalis, herpes labialis, mucocutaneous orofacial disease, herpetic gingivostomatitis, and herpetic paterecleris caused by herpes simplex virus [31],[32]; and HIV-related lesions that include Kaposi sarcoma, non-Hodgkin lymphoma, and necrotizing ulcerative periodontitis [33],[34]. The other viral components of OM are bacteriophages, whose main role is bacterial lysis [35]–[37]. It has also been proposed that the viruses in saliva serve as carriers for pathogenic genes within the oral environment [38]. Compared to other microbial groups, protozoa are the minority component of OM. In general, oral protozoa are non-pathogenic commensals typically found in individuals with exiguous oral hygiene or complete edentulism [34]. However, Entamoeba gingivalis and Trichomonas tenax have been reported to be implicated in several periodontal conditions (e.g., periodontitis and gingivitis) [39].
Members of the Bacteria domain comprise the greatest microbial diversity and abundance of OM. Studies originating from the eHOMD have shown that oral bacteria are located at specific sites within the oral cavity, including the cheek, gingival sulcus, teeth, tongue, soft and hard palate, and tonsils, as well as planktonic bacteria present in salivary fluid [2],[4],[40],[41]. Furthermore, the supragingival, subgingival, interdental, and tongue regions are different oral areas that possess a distinctive microbiota composition [42]–[45]. Within the mouth, the predominant microbial habitats are governed by the genus Streptococcus, followed in abundance by Haemophilus in the buccal mucosa, Actinomyces in the supragingival plaque, and Prevotella in the subgingival plaque. In saliva, Streptococcus, Prevotella, Veillonella, Neisseria, and Haemophilus are the most abundant genera [46].
According to Cho et al. [2], the oral cavity can be organized into three metaniches. The P-GCF metaniche is formed by the bacterial genera on supragingival dental plaque and gingival crevicular fluid, dominated by Actinomyces and Corynebacterium (phylum Actinomycetota), Capnocytophaga and Tannerella (phylum Bacteroidota), Fusobacterium and Leptotrichia (phylum Fusobacteriota), and Aggregatibacter (phylum Pseudomonadota). The S-T-HP metaniche is formed by the bacteria present in the saliva, tongue, and hard palate, which is dominated by the genera Granulicatella and Veillonella (phylum Bacillota), Alloprevotella, Porphyromonas and Prevotella (phylum Bacteroidota), and Neisseria (phylum Pseudomonadota). Finally, the U-C metaniche, which includes the cheek and sublingual area, is mainly dominated by Gemella and Streptococcus (phylum Bacillota), and Actinobacillus and Haemophilus (phylum Pseudomonadota). Figure 1 shows the metaniches of OM linked to specific oral anatomical regions.
On the other hand, Li et al. [47] proposed that OM are distributed into three niches: saliva, tooth surface, and soft tissue surface, with the former including the buccal mucosa, gingiva, tongue, and palate [48]. Members of Bacillota are more abundant in the saliva, while the members of the phyla Actinomycetota and Fusobacteriota are more prevalent in dental plaque [49]. A study of the salivary microbiota in a Qatari population found that the most abundant genera in the salivary microbiota were Gemella, Haemophilus, Neisseria, Porphyromonas, Prevotella, Streptococcus, and Veillonella [50]. Nevertheless, the microbial composition of saliva from Japanese subjects consisted of Granulicatella adiacens, Neisseria flavescens, Rothia mucilaginosa, Streptococcus mitis, and Streptococcus salivarius [51]. These variations can be affected by dietary, environmental, and genetic factors [52]. Furthermore, saliva exerts a great influence on the microbial adhesion and colonization processes [53] and encompasses a range of defense proteins that contribute to oral mucosal immunity, including α-amylase, antimicrobial peptides, lysozyme, mucin, statherin, peroxidases, and salivary immunoglobulins [54].
The tooth surface provides an ideal environment for bacterial growth and plaque formation. Dental plaque has been shown to harbor higher α-diversity, microbial richness, and uniformity than tongue and saliva samples [55]. Anaerobic bacteria such as Actinomyces, Fusobacterium, and Veillonella are primarily present in the subgingival plaque [28]. The microbial composition on the tooth surface is also shaped by the physiology and anatomy of the perigingival region and the tooth surfaces. Moreover, the crown surface of a single tooth can be categorized into distinct regions with notable variations in bacterial composition [56],[57]. For example, Streptococcus spp. are found on the labial surface of canines and incisors, but rarely on the lingual surface [54],[57]. Although Streptococcus is the predominant genus in mucosal tissues [28], there are differences between the components of oral mucosal tissues. The tongue exhibits a higher diversity and greater density of microorganisms compared to other mucosal surfaces [48]. In this respect, facultative and obligate anaerobes, such as Actinomyces, Haemophilus, Leptotrichia, Neisseria, Porphyromonas, Prevotella, Streptococcus, and Veillonella, are the major microorganisms on the tongue [55].
The interplay among microbial communities of different species can be mutually beneficial, as the presence of one microorganism creates an environment conducive to another, and the metabolic byproducts of one species serve as nutrients for another, demonstrating syntrophism [18]. As a result, these microbial groups engage in complex metabolic exchanges, making it essential to adopt a metabolomic perspective when studying OM [58]. In contrast, antagonistic interactions are also established in OM, facilitated by adhesion-binding sites and direct competition for nutrients, by the secretion of antibiotic substances and bacteriocins, and by the induction of conditions such as low pH that are unfavorable for other microbiota members [12]. Simultaneous horizontal gene transfer and homologous recombination contribute to the diversity and interdependence of members of OM [59].
In reaction to factors like chewing, salivary flow, and mastication, these sites within the mouth display distinct physicochemical characteristics, such as oxygen tension, nutrient content, mechanical forces, and pH levels, all of which influence the selection of microorganisms for each specific oral niche. In addition, structures such as the teeth and tongue offer a physical foundation that supports the establishment of oral microbial biofilms.
Oral microbial biofilms are intricate ecological systems that contain a variety of oral microorganisms and may be linked to several oral diseases [47]. The initial colonizing bacteria are often several Streptococcus species, including S. gordonii, S. mitis, S. oralis, and S. sanguinis, which specifically bind to their corresponding salivary receptors via surface adhesins [60]. This binding is pivotal for the development of multispecies biofilms and relies on the adhesins present on one bacterium's surface and the complementary polysaccharide-containing receptors found on the other species [61]. In its mature state, the biofilm consists of various microorganisms, proteins, lipids, extracellular polymeric substances, and extracellular polysaccharides from saliva and food [62],[63]. As the oral microbial biofilms mature, the predominant bacteria shift from Streptococcus in the initial stage to strict anaerobes such as Capnocytophaga, Fusobacterium, Porphyromonas, Prevotella, Veillonella, and Actinomyces in the later stages [64]–[67]. In particular, Fusobacterium nucleatum plays a crucial role in establishing interdependent interactions with other microbiota members, functioning as a link between early and late colonizers [68]. This is largely due to the strong and extensive adhesive properties of its outer membrane proteins [69], which mediate colonization with Gram-positive bacteria such as Staphylococcus aureus, S. gordonii, and Streptococcus mutans, and even with the yeast Candida albicans [47],[70],[71]. The close physical proximity between microorganisms in the biofilm allows the existence of communication between either the same or different bacterial species, facilitated by chemical signals that are synthesized and released by the bacteria in the biofilm. These signals can be categorized into two types: one associated with cell density and quorum sensing, and the other involving signals generated by bacteria at different stages of their growth [72],[73].
Several factors may influence the composition of OM, such as age, diet, drugs, exposure to toxic substances, use of antimicrobials, genetic predisposition, and pregnancy [74]. Food components, including sugars, fats, and vitamins, are considered to be the most influential factors that affect microbial composition, including both the community structure and diversity of OM [47]. Some studies have reported that OM of individuals in lower socioeconomic conditions tends to have reduced biodiversity, with higher concentrations of bacteria such as Achromobacter xylosoxidans, Aggregatibacter segnis, and Neisseria cluster II. Conversely, higher socioeconomic status individuals exhibit elevated levels of Prevotella histicola, Megasphaera micronuciformis, Veillonella atypica, Veillonella parvula, Rothia mucilaginosa, F. nucleatum, G. adiacens, and Tannerella forsythia [75],[76]. Table 1 shows several factors promoting changes in OM.
Factors | Major findings | Reference |
Health conditions | Poor: -Lower microbial diversity -Increases abundance of Aggregatibacter segnis, Achromobacter xylosoxidans, and Neisseria cluster II Good: -Increases abundance of Megasphaera micronuciformis, Veillonella atypica, V. parvula, Rothia mucilaginosa, Prevotella histicola, Fusobacterium nucleatum, Granulicatella adiacens, and Tannerella forsythia |
[75],[76] |
Antibiotic treatment | -Decreases Actinomycetota members | [76],[77] |
-Reduces diversity index -Decreases abundance of Actinomycetota, Bacteroidota, and Fusobacteriota members -Increases abundance of members of Pseudomonadota and Aggregatibacter aphrophilus |
||
-Decreases the abundance of Neisseria, Streptococcus, and Veillonella and of members of Rikenellaceae | [78]–[80] | |
-Increases antibiotic-resistant genes | [81] | |
Dietary patterns | -Higher proportion of Streptococcus in breastfed infants -Increases abundance of Actinomyces and Prevotella in formula-fed infants |
[82] |
-Positive correlation between carbonated beverages and the abundance of Bacteroidota, Pseudomonadota, Fusobacterium, and Veillonella | [83] | |
-Alcohol consumption increases Streptococcus mutans and inhibits Fusobacterium activity | [84] | |
Smoking | -Decreases abundance of Streptococcus sanguinis and S. parasanguinis -Increases abundance of Fusobacterium naviforme and F. nucleatum |
[85] |
Smoking | -Decreases abundance of Pseudomonadota, Neisseria subflava, Corynebacterium, Capnocytophaga, Peptostreptococcus, and Leptotrichia -Increases abundance of Bacillota, Actinomycetota, Atopobium and Streptococcus |
[86] |
-Increases microbial diversity -Increases abundance of Fusobacteriota, Actinomycetota, Streptococcus, Prevotella, and Veillonella |
[87] | |
Pregnancy | -Increases abundance of Neisseria, Porphyromonas, and Treponema -Decreases abundance of Streptococcus and Veillonella |
[88] |
-Increases abundance of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans | [89] |
Antibiotics such as amoxicillin, azithromycin, ciprofloxacin, and clindamycin have the most significant effects on the microbiota, resulting in a reduction of Actinomycetota [76]. These antibiotics impact both the functions and composition of OM while also inducing particular metabolic alterations during antibiotic treatments [79],[90]. A prospective cohort study conducted in patients with endodontic infection treated with amoxicillin found that antibiotic therapy decreased the microbial diversity index, with the relative abundance of members of Actinomycetota, Bacteroidota, and Fusobacteriota decreasing after 1 week of treatment [77]. In contrast, the abundance of members of Pseudomonadota and Aggregatibacter aphrophilus was detected at 1 month after antibiotic therapy. Other studies have also shown that amoxicillin reduces the abundance of the genera Neisseria, Streptococcus, and Veillonella and members of the family Rikenellaceae in OM [78]–[80]. In addition to these antibiotic effects on OM, the increase in the abundance of genes linked to antibiotic resistance in the buccal cavity is also important [81]. It has been observed that certain prevalent oral fungi show resistance to antifungal azoles [91], with genes related to resistance against fluconazole and ketoconazole being significantly expressed in C. albicans obtained from individuals suffering from periodontal disease [92].
The OM of infants who were breastfed showed a greater proportion of Streptococcus, while infants who were formula-fed exhibited a greater abundance of Actinomyces and Prevotella. In addition, breastfed and mixed-fed infants were less likely to develop oral candidiasis than solid food-fed infants [82]. This significant difference in the oral microorganisms between breastfed and formula-fed infants may be related to the production of hydrogen peroxide, an antimicrobial substance [93]. In adults, dietary shifts can also alter the OM and help prevent the growth of microbial pathogens [94]. Several nutrient components, such as dietary fiber, various types of fatty acids, and carbohydrates are associated with OM diversity and community structure [47],[95]. For example, the intake of carbonated beverages is positively associated with the abundance of members of the phyla Bacteroidota and Pseudomonadota and the genera Fusobacterium and Veillonella and with the occurrence of caries [83]. Sugar alcohols, including sorbitol, erythritol, and xylitol, are commonly used as sugar substitutes for preventing caries, although they also alter the composition of the salivary microbiota [96]. Similar to sugar, overconsumption of alcohol, with the exception of red wine, can disrupt the balance of OM by increasing the levels of Gram-positive bacteria such as S. mutans, while simultaneously inhibiting the Fusobacterium activity due to elevated acetaldehyde concentrations [74],[84],[97].
Cigarette smoking introduces its own bacterial load to the mouth, including species such as Bacillus spp. and Clostridium spp. [86]. The toxic substances in cigarettes can lead to the depletion of beneficial oral bacteria, facilitate pathogen colonization, and ultimately result in disease, either directly or through mechanisms like biofilm formation and immunosuppression [85],[98],[99]. These changes increase processes such as salivary acidification and oxygen depletion, leading to the development of anaerobic bacteria [76]. Among smokers, a higher presence of detrimental commensals such as S. sanguinis and Streptococcus parasanguinis, alongside abundant anaerobic microorganisms like F. nucleatum and Fusobacterium naviforme, was reported. In turn, this was accompanied by a greater taxonomic diversity and richness, which closely reflected a microbiota composition typically linked to disease, even in clinically healthy individuals [85]. In particular, periodontal pathogens belonging to members of phylum Synergistota and the genera Cardiobacterium, Selenomonas, and Fusobacterium, along with respiratory pathogens that belong to the genera Haemophilus and Pseudomonas, colonized the initial biofilms of smoking individuals [100].
Other studies on smoking subjects have reported that the abundance of Pseudomonadota, Neisseria subflava, and Corynebacterium in OM are substantially decreased, while members of Bacillota and Actinomycetota are increased. Furthermore, the Leptotrichia, Peptostreptococcus, and Capnocytophaga genera showed reduced abundance in current smokers compared to those who had never smoked, while the Streptococcus and Atopobium genera were found to be more prevalent [86]. In a systematic review that included 36 studies, Senaratne et al. [87] concluded that tobacco users exhibited increased bacterial richness and diversity, with substantial enrichment of Fusobacteriota and Actinomycetota at the phylum level, and Veillonella, Prevotella, and Streptococcus at the genus level.
Interestingly, one study revealed that microbial richness and diversity showed no significant variations when comparing smokers to non-smokers [101]. This discrepancy was explained to be due to several factors, including diet, ethnicity, and environment. Research has demonstrated that following a specific duration of smoking cessation, OM composition in former smokers aligns closely with that of never-smokers, suggesting that quitting smoking aids in reestablishing a balanced microbiome [86],[98],[102]. Recent evidence has shown that the potential impacts of smoking on OM can encompass impairing immune defenses, forming anaerobic conditions, altering salivary pH and bacterial adhesion, and introducing antimicrobial effects through harmful chemicals in cigarettes [86],[98].
In the course of pregnancy, women experience significant and complex hormonal fluctuations that influence the composition of OM [103]. Several studies have found an elevated risk of periodontal disease during pregnancy, along with alteration in OM composition [104],[105]. In general, the abundance of Treponema, Porphyromonas, and Neisseria increases during pregnancy, while the abundance of Veillonella and Streptococcus decreases [88]. The presence of Porphyromonas gingivalis in periodontal pockets has been associated with microbial invasion of the amniotic cavity, which may contribute to preterm labor [106]. Moreover, an increase in Aggregatibacter actinomycetemcomitans and P. gingivalis during pregnancy has been noted in the gingival sulcus compared to non-pregnant women [89]. In the last trimester, the most abundant bacterial genera are Capnocytophaga sputigena, Lachnoanaerobaculum (formerly Eubacterium) saburreum, F. nucleatum, F. nucleatum subsp. polymorphum, Leptotrichia buccalis, Prevotella melaninogenica, Parvimonas micra, Prevotella intermedia, S. aureus, Streptococcus anginosus, Streptococcus intermedius, Streptococcus oralis, S. mutans, S. gordonii, Selenomonas noxia, and V. parvula [74],[76],[103],[107],[108].
It has been demonstrated that disease processes alter the microbial diversity of healthy OM [109]–[111]. One study reported that α-diversity was lowest in caries-associated microbiota compared to that of healthy OM, with statistically significant differences observed between caries and healthy OM saliva samples. Regarding β-diversity, the microbial composition of caries samples was distinct from that of saliva samples classified as caries-free or caries-active, particularly when bacterial abundance was taken into account [109]. In the case of periodontal disease, a comparative analysis of the oral mucosa and subgingival plaque from healthy individuals and periodontitis patients revealed increased microbial diversity in the periodontitis group [110]. Another study [111] evaluating α-diversity in saliva and subgingival samples found no significant differences between healthy and periodontitis groups. However, within the periodontitis group, higher diversity was observed in saliva and subgingival areas compared to supragingival sites. Moreover, β-diversity analysis further confirmed distinct microbial community clustering between healthy and diseased groups in both supragingival plaque and saliva samples, although no significant differences in overall diversity or evenness were detected.
Dental caries occur when acids generated by the breakdown of dietary carbohydrates by commensal oral bacteria cause demineralization of the tooth surface. Key contributors to the development of caries encompass microbial dental plaque, consumption of sugars, and an acidic oral environment [112]. Nevertheless, saliva helps counteract these effects by buffering acids, raising pH levels, and restoring lost ions through a process termed remineralization [113]. Without adequate removal of biofilm (due to poor oral hygiene), bacteria metabolize sugars, releasing acids that erode tooth enamel and promote caries formation [112].
Acid generation in dental biofilms is predominantly linked to lactobacilli and streptococci, with the latter dominating. Oral streptococci exhibit notable variability in their acidogenicity and tolerance to acidic conditions. S. mutans and Streptococcus sobrinus are capable of catabolizing sucrose by converting it primarily into lactate, as opposed to generating a blend of alcohols and weaker acids observed in other species [12]. Moreover, certain strains of S. mitis exhibit acid production comparable to streptococci of the mutans group at pH 5.5, whereas other strains of this species, along with S. gordonii, S. sanguinis, and S. oralis subsp. dentisani, are significantly less acidogenic [114]. Nevertheless, the pH within dental biofilms is influenced not only by acid generation but also by the accumulated metabolic activities of the microbial community. Determinate oral microorganisms such as Streptococcus cristatus, S. gordonii, S. oralis subsp. dentisani, S. parasanguinis, and S. sanguinis generate ammonia as a byproduct of arginine metabolism [115]. Additionally, Actinomyces and Haemophilus parainfluenzae contribute to ammonia production through urease activity [116], enhancing the buffering capacity of the biofilm's microenvironment. Consequently, elevated alkali generation driven by arginine deiminase and urease pathways within the mouth is strongly related to caries resistance [117].
An acidic condition in the oral environment triggers the production of enzymes and provokes changes in the microbial composition, favoring the selection of acid-tolerant aerobic microorganisms. Although S. mutans has been considered uniquely responsible for caries in research using culture methods, more recent studies have found that other species are also involved, including Lactobacillus spp., Bifidobacterium spp., and Actinomyces spp. [118]. The application of molecular techniques has opened new perspectives in understanding which bacteria are linked to distinct kinds and phases of dental caries, which can be divided into three main types: (i) early caries, characterized by the appearance of white spot lesions on the enamel, which are the initial stages of tooth decay; (ii) dentin caries, which occurs when the decay extends beyond the enamel and reaches the underlying dentin, leading to deeper tissue damage; and (iii) root caries, which specifically affect the cementum or dentin of the tooth roots, typically in individuals with gum recession or exposed roots. In contrast, in childhood caries, several studies have shown a differential involvement of OM. Ma et al. [119] reported various genera such as Actinomyces, Porphyromonas, and Streptococcus, which were linked to severe caries in early childhood, constituting potential biomarkers of dental caries in the initial dentition. Other studies have reported the occurrence of the genera Dialister, Filifactor, Prevotella, and Lactobacillus in the pathogenesis of dental caries in Chinese children [120]. In Canadian children with severe early-childhood caries, Veillonella spp., Porphyromonas spp., and S. mutans were more abundant, while S. gordonii and S. sanguinis dominated in the non-caries group [121].
Tooth decay refers to the irreversible loss of minerals from the tooth's hard tissues, including the enamel and dentin. It is primarily caused by the organic acids produced by bacteria within the dental plaque. These acids are generated through the anaerobic breakdown of dietary sugars, especially sucrose, which occurs after the intake of sugary foods [122].
The primary driver of periodontal diseases is the accumulation of dental plaque on the tooth surfaces, often stemming from inadequate oral hygiene. These conditions are classified into two main types: gingivitis and periodontitis [121]. Periodontal diseases generally arise from microbial biofilm (dental plaque) and involve a range of bacterial species that proliferate in number due to plaque dysbiosis [123]. Persistent inflammation may result in the establishment of periodontal pockets, which disrupt the local nutrient balance and redox state, fostering greater microbial diversity and richness within the biofilm, ultimately exacerbating dysbiosis [124].
A healthy subgingival microbiome is predominantly composed of Gram-positive bacteria such as Actinomyces spp. and Streptococcus spp., which serve as initial colonizers and play a critical role in forming the foundational layer of dental plaque. F. nucleatum, the second most prevalent species, functions as an intermediary colonizer, facilitating connections between diverse bacterial species as the plaque matures [46]. In addition, Gram-negative bacteria like Capnocytophaga spp. and Veillonella spp. contribute significantly to biofilm formation. Furthermore, Gram-positive species such as Rothia spp. and Corynebacteria have been recognized for their role in spatial arrangements within biofilms [125]. The onset of gingivitis induces a shift in the subgingival microbiome, marked by an increase in Gram-negative bacteria such as Selenomonas spp., F. nucleatum subsp. polymorphum, and Prevotella spp., accompanied by a decline in Gram-positive species. This microbial transition correlates with elevated inflammatory cytokine levels in gingival crevicular fluid [126],[127].
Gingivitis arises from the continuous formation of microbial biofilms, a process that may be intensified by localized risk factors, including calculus accumulation, misaligned teeth, and iatrogenic restorations. These elements are considered primary contributors to the onset and progression of gingivitis [128]. Without proper intervention, gingivitis can advance to periodontitis, which is a severe condition mainly marked by the destruction of alveolar bone and by the development of periodontal pockets [129]. Key anaerobic bacterial species implicated in driving the inflammatory response that underpins gingivitis are Actinomycetota, Campylobacter, Eiknella, Fusobacterium, Capnocytophaga, and Prevotella [130].
As previously mentioned, periodontitis constitutes a chronic inflammatory disease of bacterial origin that results in irreversible damage of the periodontal connective tissues, resorption of alveolar bone, as well as tooth loss [129]. The most prevalent forms of periodontitis are linked to anaerobic, Gram-negative bacteria, including P. gingivalis, P. intermedia, and Treponema denticola, which produce virulence factors like cysteine protease (PrtH), dentilisin, and gingipain, which exhibit potent proteolytic activity [40],[131]. The immune system reacts strongly to the presence of these microorganisms in the gum, triggering the release of pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) [132]. Periodontitis is further characterized by elevated serum levels of C-reactive protein (CRP) and by a reduction in anti-inflammatory markers like interleukin (IL)-10 [133]. Clinically, this manifests initially as severe inflammation of the gums, progressing to the irreversible destruction of the tooth-supporting structures, including the alveolar bone and periodontal ligament [134].
Among healthy subjects, Candida species are naturally present on mucosal surfaces, including the oral cavity, gastrointestinal tract, nasal passages, reproductive organs, and skin. Oral candidiasis, often called “thrush”, is a fungal infection of the oral mucosa primarily provoked by the overgrowth of Candida spp., with Candida albicans being the most prevalent species. Factors that contribute to its development encompass the use of specific medications, impaired salivary gland function, diets high in carbohydrates, and dental prosthetics [135]. Saliva contains antimicrobial agents such as amylase, lactoferrin, lysozyme, glycosylated proline-rich proteins, and antibodies specifically targeting Candida [136]. In addition, dental materials and structures can create a conducive microenvironment for Candida growth, promoting colonization in conditions with low oxygen and acidic pH. This process is further facilitated by diets rich in carbohydrates that enhance Candida adherence to oral epithelial cells. Moreover, other risk factors linked to oral candidiasis include cancer, cigarette smoking, diabetes, and compromised immune function [74].
Oral lichen planus (OLP) is a persistent inflammatory condition that primarily affects the oral mucosa and is classified as a mucocutaneous disease. Although its etiology and pathogenesis remain largely unclear, OLP has been associated with several underlying conditions and triggers, including hypersensitivity reactions to dental materials, autoimmune disorders, microbial infections (bacterial and viral), certain medications, and vaccines [137]. Research into OM's role in OLP is limited. However, Bornstein et al. [138] identified elevated bacterial counts of C. sputigena, Eikenella corrodens, Lactobacillus crispatus, Mobiluncus curtisii, Neisseria mucosa, Prevotella bivia, P. intermedia, Streptococcus agalactiae, and Staphylococcus haemolyticus at OLP lesion sites. Similarly, Ertugrul et al. [139] noted increased colonization by pathogens such as P. gingivalis, A. actinomycetemcomitans, T. denticola, P. intermedia, and T. forsythia in individuals with OLP compared to controls. Furthermore, Choi et al. [140] observed a reduction in Streptococcus alongside a proliferation of bacteria linked to gingivitis and periodontitis in OLP lesions. More recently, Yan et al. [141] found a notable rise in the relative abundance of Pseudomonas, Aggregatibacter, Campylobacter, and Lautropia in OLP.
Although this topic is beyond the scope of this review, we summarize recent data from scientific literature linking the onset or exacerbation of specific systemic diseases to disruptions in OM. This microbiome, along with associated inflammatory mediators, can reach the systemic organs through two main pathways: the circulatory system and the digestive tract. The first route, bloodstream transmission, occurs due to the anatomical proximity of periodontal pockets to blood vessels. The second route involves OM reaching the digestive tract through alimentary dissemination [142]. However, the exact mechanisms of invasion need to be determined in each case [143]. Table 2 shows how OM is involved in several systemic diseases.
Phylum | Genera | Systemic diseases | Reference |
Bacillota | Lactobacillus | Cardiovascular | [144] |
Selenomonas | Systemic lupus erithematosus Lung cancer |
[145],[146] | |
Solobacterium | Bacteremia | [147] | |
Streptococcus | Diabetes Cardiovascular Chronic obstructive pulmonary Colorectal cancer |
[144],[148]–[150] | |
Veillonella | Hirschsprung's disease-associated enterocolitis Cardiovascular Lung cancer Inflammatory bowel disease |
[146],[151]–[153] | |
Bacteroidota | Capnocytophaga | Diabetes Lung cancer |
[146],[154] |
Bacteroidota | Porphyromonas | Diabetes Cardiovascular Rheumatoid arthritis Adverse pregnancy outcomes Inflammatory bowel disease Pancreatic cancer Esophageal cancer |
[155]–[162] |
Prevotella | Metabolic dysfunction Cardiovascular Rheumatoid arthritis Inflammatory bowel disease Systemic lupus erithematosus |
[151],[163]–[166] | |
Tannerella | Diabetes Cardiovascular Rheumatoid arthritis Esophageal cancer |
[160],[167]–[169] | |
Fusobacteriota | Fusobacterium | Diabetes Cardiovascular Chronic obstructive pulmonary Adverse pregnancy outcomes Ulcerative colitis Colorectal cancer |
[170]–[175] |
Pseudomonadota | Aggregatibacter | Diabetes Cardiovascular Inflammatory bowel disease Pancreatic cancer |
[176]–[180] |
Campylobacter | Inflammatory bowel disease | [181] | |
Haemophilus | Chronic obstructive pulmonary | [182] | |
Moraxella | Chronic obstructive pulmonary | [183] | |
Spirochaetota | Treponella | Diabetes | [169] |
Although many studies establish a clear association between the gut microbiome and several mental disorders [184], evidence on the influence of OM and its pathophysiological mechanisms in relation to neuropsychiatric disorders is more limited [185]. However, several studies have identified specific OM in individuals with mental disorders, leading to the hypothesis of a relationship between these two components. This hypothesis assumes that the central nervous system (CNS) is able of altering the oral environment to favor the selection of specific microbial groups, as is the case for the gut microbiota [186], as well as influence poor oral condition in patients with mental disorders [187]. Several reviews have collected the involvement of OM or oral diseases in diverse neurodegenerative, neuropsychiatric, and psychological conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), autism spectrum disorder (ASD), depression, anxiety, and psychological stress [188],[189]. In addition, other mental health disorders and adverse brain-related conditions have been occasionally implicated in OM dysbiosis, such as epilepsy and cerebral palsy, schizophrenia, and bipolar disorder [190].
It has been postulated that OM may directly and indirectly affect brain function through several mechanisms. For instance, directly through microbial translocation to the brain via the trigeminal nerve and olfactory system, which connects the oral cavity to the olfactory bulb in the brain [191],[192]. Persistent oral diseases may impair the oral mucosal barrier [193], facilitating microorganism or lipopolysaccharide (LPS) access to bloodstream through mechanical damage (brushing or chewing), contributing to a severe inflammatory response by stimulating endothelial cells that express TNF-α and IL-1β receptors, which signal perivascular macrophages, driving neuroinflammation and activation of the hypothalamic–pituitary–adrenal (HPA) axis [194]. Moreover, these inflammatory mediators lead to the breakdown of the blood–brain barrier (BBB) [195], which is linked to inflammation and cognitive decline in certain mental conditions [196],[197]. P. gingivalis is recognized for its ability to invade the bloodstream and travel to the brain, where it establishes colonies and segregates neurotoxic proteases known as gingipains [198]. Gingipains are implicated in disrupting the processing of the transmembrane protein β-amyloid precursor protein (APP), which plays a pivotal role in maintaining neuronal growth and protection, as well as synaptic stability [199]. Additional pathways for entry into the brain include the choroid plexus, circumventricular organs, and leptomeninges [197],[200]. On the other hand, OM can indirectly influence the brain function via the oral–gut–brain axis [201]. The translocation of oral microbial species to the gut via saliva can affect the shape of the gut microbiota [202]. Therefore, the mouth could act as a reservoir for gut pathogenic microorganisms that can trigger the gut immune system and provoke persistent inflammation [203],[204], thereby leading to increased intestinal epithelial permeability [205],[206]. Systemic inflammation can produce changes in neurovascular function, resulting in increased BBB permeability, decreased nutrient delivery, and accumulation of toxins in the brain [198],[207]. Figure 2 shows a schematic representation of the oral–gut–brain axis.
The increased relative abundance of oral bacteria in fecal samples can be explained by two main hypotheses. The expansion hypothesis suggests that oral bacteria invade the gut ecosystem and proliferate, whereas the marker hypothesis proposes that these bacteria merely pass through the gut, with their relative increase indicating a depletion of native gut microbiota. In this regard, the detection of oral bacteria in feces associated with inflammation, intestinal diseases, and depletion of the gut microbiome supports the marker hypothesis [208]. Costa et al. [209] investigated the relationship between OM and the gut microbiome by sequencing the V4 region of the 16S ribosomal RNA gene and performing an amplicon sequence variant (ASV) analysis. Although the composition of both microbiomes was distinct, they identified a subset of 61 ASVs shared between the oral and gut microbiomes of the same individuals. Of these, 38 ASVs (62%), encompassing 23 genera, were more prevalent in oral samples, whereas 17 ASVs (28%), representing 12 genera, were more abundant in the gut. Only three genera, Limosilalactobacillus and Weissella (phylum Bacillota) and Atopobium (phylum Actinomycetota), showed similar abundance in both microbiomes. The predominance of shared ASVs in the oral cavity suggests that oral-to-gut transmission is the primary route of bacterial translocation, a process likely more common in healthy individuals. Despite the continuous ingestion of oral bacteria via saliva and food, most fail to reach the gut in a viable form due to physiological barriers such as gastric acidity, bile acids, the host immune response, and competition with resident gut bacteria. These factors make colonization of the gut by oral bacteria largely inefficient. However, Kageyama et al. [210] suggested that this translocation may be influenced by aging and the accumulation of dental plaque. Certain oral bacterial species have been identified in cases of intestinal disorders and proposed as potential biomarkers for gastrointestinal diseases [211]. These findings highlight the importance of the oral-gut microbiome axis and indicate that maintaining a balanced microbial environment in both ecosystems could be pivotal for gastrointestinal health. Interestingly, alterations in OM of patients with neurodegenerative disorders closely resemble changes observed in the gut microbiome of individuals with AD and PD [212]. Similarly, gut microbiome dysbiosis in neuropsychiatric conditions has been linked to shifts in bacterial genera within OM, particularly in ASD, depression, and anxiety, while distinct patterns were observed in schizophrenia [184].
AD is a progressive neurodegenerative condition marked by cognitive decline, memory dysfunction, and impaired activities in daily living [213]. AD is primarily characterized by the accumulation of amyloid beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain, which disrupt normal neural function and lead to the gradual deterioration of cognitive abilities. Amyloid products are part of the host's immune response to pathogens in both the peripheral systems and CNS. These products are generated through the protease-mediated cleavage of the APP. APP is a type I transmembrane protein that can be processed by several enzymes, such as γ-secretase, α-secretase, and β-secretase [214]. Epidemiological studies have suggested the existence of a relationship between periodontal disease together with OM and cognitive decline, dementia, and the development of AD [133],[215]–[217]. For example, a nationwide retrospective cohort study conducted in Taiwan revealed that subjects with persistent gingivitis and periodontitis were more likely to develop dementia than those who had healthy gums [218]. In addition, Chen et al. [219] noted that chronic periodontitis was related to a more elevated risk of developing AD.
A large body of evidence has established a direct causal link between various microbiota of OM and AD. P. gingivalis has been shown to induce the accumulation of Aβ plaques and NFTs following an experimental oral infection in mice, which also demonstrated that oral administration of gingipain inhibitors reduced P. gingivalis levels and decreased Aβ42 generation in mouse neural tissue [220]. Other studies have reported that the persistent systemic P. gingivalis infection induced Aβ accumulation in inflammatory monocytes/macrophages through the stimulation of CatB/NF-κB signaling [221], as well as in the human neuroblastoma cell line SH-SY5Y [222]. Moreover, the administration of P. gingivalis induced pro-inflammatory responses, Aβ production in the brain, and impaired cognitive performance in Sprague-Dawley rats and C57BL/6J and SAMP8 mice [223],[224]. Intraperitoneal injection of P. gingivalis LPS into male C57BL/6J and SAMP8 mice resulted in a decrease of the neprilysin expression in the hippocampus [223], and lower levels of neprilysin have been linked to increased Aβ accumulation in AD [225],[226].
A. actinomycetemcomitans has been involved in AD via its capacity to provoke inflammatory responses, influence the CNS, and induce the secretion of β-amyloid [227]. In addition, A. actinomycetemcomitans can enhance the production of inflammatory cytokines and toll-like receptors in brain cells, resulting in the elevated expression of pro-inflammatory cytokines like TNF-α, IL-6, and IL-1β [228]. T. denticola, together with T. forsythia and P. gingivalis, form the “red complex”, a well-established polybacterial pathogenic consortium in periodontitis. These bacteria play a crucial role in local dysbiosis in OM and lead to the disruption of the immune response of the host [229]. Importantly, Treponema species have been found in the brains of individuals with AD [230]. Animal studies have shown that oral inoculation of T. denticola in C57BL/6 mice results in the accumulation of Aβ1-42 within the hippocampus and in neuronal apoptosis, indicating a possible connection with memory dysfunction [231],[232]. F. nucleatum has been proposed as a potential microorganism involved in the development and pathogenesis of AD. In this regard, oral infection with F. nucleatum may provoke heightened learning impairment in AD-like rats. Furthermore, F. nucleatum exposure increased the Aβ1-42 and p-Tau181 expression in AD-like rats [233]. Nevertheless, F. nucleatum infection has been associated with increased local or systemic inflammation, which affects the permeability of the BBB. This subsequently triggers CNS and systemic immune activation, neuroinflammation in the CNS, the deposition of Aβ plaques within the brain, and the development of AD [234]. In addition, Watanabe et al. [235] reported that Cnm-positive S. mutans were more frequently found in the saliva of individuals with cerebral microbleeds. Moreover, cognitive function was lower in individuals with Cnm-positive S. mutans that expressed collagen-binding activity. Cerebral microbleeds are considered a risk factor for dementia, and the collagen-binding Cnm protein expressed by Cnm-positive S. mutans contributes to the formation of these cerebral microbleeds [236].
Additionally, research has established further links between AD and OM. For instance, Liu et al. [237] reported a lower abundance and biodiversity of the salivary microbiota in individuals with AD compared to those of healthy controls. These authors noted relatively greater levels of Sphaerochaeta, Leptotrichia, and Moraxella, and also a substantial reduction in the abundance of Rothia in the saliva of subjects with AD. In another study, patients with AD had lower microbial diversity than controls, with a significantly increased abundance of members of the order Lactobacillales and the family Streptococcaceae, and a significantly decreased abundance of the genus Fusobacterium [238]. In a cohort study conducted in Canada, Cirstea et al. [239] found that the OM of AD patients had higher microbial diversity, with a lower abundance of the Streptococcaceae and Actinomycetaceae families and a greater abundance of members of the family Weeksellaceae. The periodontitis-associated oral microorganism P. gingivalis was more prevalent in AD patients. On the other hand, Fu et al. [240] found increased frequencies of Capnocytophaga spp., Eubacterium infirmum, Prevotella buccae, and Selenomonas artemidis in the AD group. More recently, Issilbayeva et al. [241] conducted a case-control study of OM diversity in AD patients compared to healthy Central Asian seniors and reported that the OM of AD had a higher microbial diversity, with an increase in members of Bacillota and a decrease of Bacteroidota members in the AD group. At the genus level, these authors found five prevalent genera in AD patients: Bacteroides (phylum Bacteroidota), Methylorubrum (formerly Methylobacterium; phylum Pseudomonadota), and Anaerostipes, Lactobacillus, and Shuttleworthia, belonging to the phylum Bacillota. However, other authors found no significant differences in microbial diversity between AD and healthy subjects [242].
The exact mechanisms by which the oral pathogens influence the onset and progression of AD remain not fully elucidated. The accumulation of essential pathogenic elements, including tau and Aβ, in the brain may stem from diverse factors [234]: (i) the migration of microbial products from the mouth to the brain, resulting in continuous activation of CNS immune cells; (ii) oral inflammation impacting neuroinflammation in the CNS; (iii) entry of OM into the brain due to increased BBB permeability; (iv) the movement of oral pathogens or their byproducts (bacterial peptidoglycan and LPS) into the peripheral system, thereby triggering pro-inflammatory monocyte/macrophage migration into the brain; and (v) the initiation of AD pathology from a precise anatomical area, owing to the direct connection between the trigeminal nuclei, locus coeruleus, proprioceptors, and periodontal free nerve endings with the CNS.
PD is marked by the progressive loss of dopaminergic neurons within the substantia nigra. The condition manifests through both motor and non-motor symptoms, including loss of smell (anosmia), rapid eye movement sleep disturbances, gastrointestinal issues such as constipation, mood disorders like depression, autonomic dysfunction, and cognitive decline [243]. One study examined differences in OM composition and the extent of oral inflammation between individuals with PD and healthy controls [244]. No differences in the periodontal parameters were found, but the levels of IL-1β, IL-1 receptor antagonist, and TNF-α were significantly higher in PD patients compared to the healthy controls [244]. These authors stated that salivary and subgingival dental plaque microbiota also diverged between individuals with PD and controls, including the higher abundance of Kingella oralis, S. mutans, Scardovia spp., Actinomyces AFQC_s, Veillonella AFUJ_s, and members of taxa Lactobacillaceae, Negativicutes, and Bacillota, whereas Lachnospiraceae AM420052_s, Treponema KE332528_s, and candidate phylum Absconditabacteria (formerly phylum SR1) were less abundant.
In a cross-sectional case-control study employing 16S rRNA gene sequencing, Rozas et al. [245] identified the OM from soft and hard tissues of individuals with PD compared to those of healthy controls. The study revealed substantial distinctions in soft tissue β-diversity and a higher prevalence of potentially pathogenic oral species in individuals with PD, such as Lactobacillus spp., T. forsythia, and P. intermedia. Subjects with PD also presented heightened levels of endogenous opportunistic pathogens, including Streptococcus constellatus, Streptococcus pneumoniae, and Mycoplasma orale. In addition, the hard tissue bacterial communities of PD patients showed no overall community differences (β-diversity) compared to the controls, although a total of 12 OTUs were substantially more abundant in patients with PD, including the genera Fusobacterium, Capnocytophaga, Alloprevotella, Prevotella, and the species Campylobacter rectus. In another study, it was reported that ligature-induced periodontitis involving subgingival plaque (LIP-SP) was shown to exacerbate dopaminergic neuron loss, microglial activation, and motor dysfunction in mice with PD induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) [246]. These authors demonstrated that the oral pathogens S. mutans and V. parvula require the presence of periodontitis to aggravate neurodegeneration and motor dysfunction in mice with PD induced by MPTP. This effect was linked to microglial activation and T helper 1 (Th1) cell infiltration in the cervical lymph nodes, brain, colon, and ileum of mice with PD. In addition, neutralizing IFNγ provided a protective effect on dopaminergic neurons in PD mice treated with S. mutans and V. parvula.
ASD is a multifaceted developmental neuropsychiatric condition marked by multiple levels of social interaction and communication difficulties. Children with ASD tend to exhibit low oral hygiene and a greater incidence of dental caries than controls [247]. This deterioration in oral hygiene may be due to some of the typical behavioral symptoms and manifestations of the condition among children, such as personal negligence, communication limitations, eating habits, self-injurious behavior, medication side effects, hypersensitivity to external stimuli, resistance to dental care, and hyposensitivity to dental pain [248].
As noted above, oral bacteria (e.g., H. parainfluenza) or their metabolites can trigger inflammation and impact neuroimmune activity by crossing the BBB [249],[250]. Research reveals that BBB permeability is heightened in children with ASD [251], permitting oral bacteria to influence the CNS by disrupting metabolic activity or inducing inflammation [252]. Dysbiosis of OM can affect complex behaviors such as emotional behavior and anxiety in two ways [253]. First, transcriptional changes result in impaired microglial function, leading to an increase in BBB permeability for microbial metabolites. When periodontal inflammation occurs in children with ASD, it may cause leakage of LPS across the BBB, which can trigger an inflammatory response and disrupt metabolic activity in the CNS. Prolonged alteration of energy metabolism in oligodendrocytes, neurons, and microglia can cause structural modifications in the amygdala, cerebellum, hippocampus, and cortex, resulting in behavioral disturbances in children with ASD. The increase in LPS in children with ASD correlates with an increase in IL-6, which acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. In addition, inflammation in the developing brain causes synaptic dysfunction, resulting in vasopressin secretion that can also affect social behavior [250],[254]. The second pathway is through the gut–brain axis, which involves a link between the CNS and gut microbiome through direct neural activation. Prolonged OM dysbiosis can lead to gut microbiota dysbiosis, which affects various behavioral aspects, such as those related to emotions and anxiety-associated states [250],[255],[256].
The OM is altered in children with ASD. α-diversity, including indices of richness, diversity, and evenness, was significantly lower in individuals with ASD in comparison to healthy controls in dental samples. Nevertheless, none of these indices exhibited substantial differences in saliva samples, although a lower level of bacterial richness was observed [257]. The most prevalent phyla in both groups were Bacillota, Pseudomonadota, Actinomycetota, Bacteroidota, and Fusobacteriota, which accounted for more than 98% and 95% of the salivary and dental microbiota, respectively. At the same time, certain genera showed notable differences in their abundance between children with ASD and healthy controls. In particular, ASD was associated with increased abundance rates of Streptococcus and Rothia (in plaques) and Haemophilus (in saliva), and decreased abundance of Prevotella and Selenomonas (in plaques), Actinomyces and Porphyromonas (in saliva), and Fusobacterium (in plaques and saliva).
In a cross-sectional study conducted by Kong et al. [258], different characteristics of intestinal and salivary microbiota were detected between subjects with ASD and neurotypical controls. The α- and β-diversity of OM showed no significant variations between autistic and neurotypical individuals. At the genus level, the ASD and control groups shared 9 of the 10 most prevalent genera, such as Haemophilus, Prevotella, Rothia, Fusobacterium, Streptococcus, Veillonella, Neisseria, and a non-recognized genus within the Neisseriaceae family. Another study compared the OM of the tongues of children with ASD to healthy controls [259]. Regardless of grouping, P. melaninogenica, H. parainfluenzae, R. mucilaginosa, and N. flavescens/subflava were the most abundant species. Thirteen species and three genera showed differential abundance between the two groups. For instance, increased abundance of Actinomyces species (A. odontolyticus and A. lingnae) and decreased abundance of Streptococcus vestibularis and Campylobacter concisus was found in the group with ASD.
More recently, Manghi et al. [260] conducted a cross-sectional study in which OM composition could effectively differentiate individuals with ASD from neurotypical siblings. The relative abundance of certain microbial species showed strong correlations with developmental coordination and social communication issues, cognitive impairment, and restrictive behaviors such as those related to eating. With respect to OM, α-diversity did not show significant differences in ASD subjects compared to controls. In addition, 48.2% of the detected species were more prevalent in the saliva of children with ASD. In this regard, the five species more strongly associated with ASD were Actinomyces johnsonii, Actinomyces hongkongensis, Cutibacterium acnes, Rothia dentocariosa, and Eikenella NML 130454. In contrast, the remaining percentage was associated with neurotypicality, including Prevotella pallens, Eubacterium sulci, Prevotella jejunii, Prevotella shaii, and Oribacterium parvum. There are also substantial distinctions in metabolic pathways linked to serotonin, γ-aminobutyric acid (GABA), and dopamine degradation, which appeared to be mainly associated with cognitive deficits [261]. Additionally, a study reported differences related to diagnosis in OM composition between 80 autistic children and 40 age-matched typically developing peers [262]. The results indicated that the bacterial genera Stomatobaculum, Solobacterium, Ruminococcaceae UCG.014, Campylobacter, and Tannerella were notably more prevalent in autistic children than in children without autism. Moreover, the first three genera, which were substantially more prevalent in the ASD group, exhibited significant correlations with social difficulties reported by parents, repetitive and restrictive behaviors, and anxiety-associated behaviors reported by parents. Furthermore, these authors found associations of these five bacterial genera with clinical features. The oral abundance of all the genera was significantly linked to more social difficulties, while Solobacterium and Ruminococcaceae UCG.014 were associated with more repetitive and restrictive behaviors, and Solobacterium, Ruminococcaceae UCG.014, and Tannerella were more linked to anxiety-like behaviors.
Anxiety disorders are defined by a range of symptoms such as excessive worry, fear in social and performance situations, panic attacks, and avoidant behaviors [263]. Within this context, although the exact pathogenesis of panic disorder is not fully understood, it is believed to be influenced by several factors, including genetic susceptibility, environmental exposures, neurotransmitter imbalances, and dysfunction of the amygdala [264].
Glutamate systems within cortico-limbic circuits engage with dopaminergic, GABAergic, serotoninergic, and other systems implicated in the stress response, suggesting a potential role in the onset of anxiety disorders [265]. Unlike glutamate, GABA serves as the main inhibitory neurotransmitter within the nervous system. Anxiety seems to result from a disruption between excitatory and inhibitory systems, leading to dysregulation [266].
The connection between panic disorder and OM has been reported in various studies [267]–[269]. Xie et al. [270] showed that the OM of individuals with panic disorder had higher evenness and higher abundance of the genera Veillonella and Prevotella and stated that OM could induce panic disorder via metabolic (arginine and proline) metabolism and inflammatory pathways. In this sense, panic disorder activates the HPA axis to activate cortisol secretion, which also affects the composition and metabolism of OM [271],[272]. In addition, great levels of cortisol released into the oral cavity, through the salivary glands, may affect oral health and OM within the context of anxiety disorders [273]. In a large-scale, population-based cohort of subjects, Malan-Müller et al. [268] found that anxiety disorder diagnosis was linked to a lower relative abundance of Neisseria elongata and to a greater relative abundance of Oribacterium asaccharolyticum.
Depression is a prevalent condition that significantly impairs psychosocial functioning and reduces quality of life [274]. It is primarily characterized by a persistent low mood but is often accompanied by distressing emotions, irritability, anxiety episodes, reduced performance in cognitive domains, apathy, social withdrawal, lack of motivation, anhedonia, hopelessness, psychomotor retardation, muscle hypotonia, and pervasive negative thoughts, including delusional beliefs in severe cases [275]. Neurotransmitters play a key role in mood disorders, with diminished dopamine signaling contributing to depressive symptoms [276]. Similarly, serotonin is implicated in mood disorders such as anxiety and depression. In this respect, although the serotonin hypothesis of depression has faced scrutiny, its influence on mood regulation is widely acknowledged [277]. The serotonin system may also serve as a pathway for circadian regulation of depression vulnerability [278]. In addition, depression is a major risk factor for suicide and involves complex pathogenic mechanisms, including hyperactivation of the HPA axis, inflammatory cytokines, and dysregulation of endogenous metabolites [279].
Members of the family Spirochaetaceae were positively linked to both anxiety and depression symptoms in adolescents [273]. A large number of other families were also positively associated with depression, but not with anxiety, such as Veillonellaceae, Lachnospiraceae XIV, Bacteroidales (F2), and Actinomycetaceae. At the genus level, Lachnospiraceae G8, Bacteroidales bacterium GP2, and Mitsuokella were positively related to depressive symptoms. In turn, at the species level, the genera positively linked to depression were Prevotella salivae, Actinomyces spp., Prevotella spp., Lachnoanaerobaculum orale, Treponema spp., Mogibacterium spp., Mobiluncus mulieris, Selenomonas spp., and Fusobacterium periodonticum. A total of 16 taxa significantly correlated with cortisol at the species level, including species linked to both anxiety and depression such as Lachnoanaerobaculum orale, Selenomonas spp., and Streptococcus spp. At the genus level, cortisol influenced the relationship between anxiety and the abundance of Actinomyces and Rothia, while at the species level, it affected associations with R. mucilaginosa and Prevotella oulorum. CRP moderated numerous links, such as those between depression symptoms and the prevalence of Alloprevotella rava, Haemophilus spp., Neisseria spp., and Streptococcus spp. Elevated cortisol levels have also been identified in the gingival crevicular fluid of women experiencing depression compared to healthy controls, correlating with increased inflammation and dental plaque formation [280]. Moreover, cortisol has been shown to modify microbial gene transcription, resulting in expression patterns similar to those found in periodontitis [281].
Wingfield et al. [282] investigated the composition of the salivary microbiota in a sample of depressed young adults. Notable variations in α- and β-diversity of the salivary microbiota were noted between depressed and healthy control cohorts. In addition, 21 bacterial taxa were identified to be distinctly prevalent in the cohort of depressed subjects, including increased abundance of Prevotella nigrescens and Neisseria spp., whereas 19 taxa presented a reduced abundance, including members of the genera Rothia, Prevotella, Treponema, Haemophilus, Schaalia, Solobacterium, Neisseria, Lepotrichia, Veillonella, and Fusobacterium. In a different study that employed a sample of 105 depressed cigarette smokers, Actinomycetota, Bacteroidota, Bacillota, Fusobacteriota, and Pseudomonadota were the most prevalent phyla, while Veillonella, Streptococcus, and Haemophilus were the most abundant genera in terms of oral microbiota [283]. These authors also reported that the group exhibiting higher depression possessed a greater OM diversity and richness. Using a genome-wide association study (GWAS), Li et al. [284] observed significant interactions between salivary-tongue dorsum microbiota in relation to anxiety and depression features. Importantly, a typical interaction was noted to be linked to anxiety and depression scores, specifically Centipeda periodontii SGB 224 × Granulicatella uSGB 3289. Furthermore, these authors identified Eggerthia, a salivary microbiota, to be related to anxiety and depression. Interestingly, a higher relative abundance of P. histicola was evident in individuals with higher CESD depressive scores and those with poor psychological quality of life scores. Subjects with higher CESD scores also presented a greater relative abundance of O. asaccharolyticum and Lancefieldella spp. [268].
Stress is caused by a difficult situation or challenging event, known as a stressor, to which the body develops either a physiological or psychological reaction called the stress response [285]. Psychological stress arises when environmental demands overwhelm an individual's ability to adapt effectively [286]. Over time, chronic stress may disrupt behavioral, physiological, and emotional processes, influencing both the onset and progression of diverse diseases [287]. Modern lifestyles, marked by elevated stress levels, intake of processed foods, and overuse of antibiotics, along with environmental fluctuations, such as heightened pollution, urbanization, and climate change, have driven the human microbiota toward an industrialized composition [288].
The experience of stress varies greatly from person to person, and when a stressor is evaluated, stress axes are activated, implicating brain regions such as the amygdala, hippocampus, and prefrontal cortex. The two primary stress-response systems are the sympathetic nervous system, also known as the sympatho-adrenomedullary (SAM) axis, which releases catecholamines, and the HPA axis, which triggers the release of cortisol. After exposure to stress, activation of the HPA axis mediates the “fight or flight” response, promoting cortisol and glucose secretion. The complexity of the stress response is not only limited to neuroanatomy or to the mediators of the SAM and HPA axes but also varies according to the duration of stressor exposure and to the timing, as well as its immediate and long-term repercussions [289]. Acute stress-induced inflammation is regulated by catecholamines, which protect the organism from potential damage or infection. Conversely, chronic stress triggers the HPA axis to release cortisol to mitigate excessive inflammation. This process includes pro-inflammatory cytokines that form a self-regulating feedback mechanism at different levels of the HPA axis [290]. The regulation of catecholamines seems to act as a protective mechanism, rapidly mobilizing immune responses to mitigate potential harm [285],[291]. Nevertheless, for preventing damage caused by an excessive inflammatory response, the stress response also activates the HPA axis, stimulating the cortisol release [292]. This activation primarily occurs via the secretion of pro-inflammatory cytokines such as TNF-α, IL-1, and IL-6. These cytokines create a self-regulating feedback loop by affecting different levels of the HPA axis, including the pituitary and adrenal glands as well as the paraventricular nucleus. As a consequence of intermittent or sustained stress, the HPA axis can become dysregulated, characterized by persistently elevated cortisol levels that may last for years, a condition called hypercortisolism, which is indicative of an overreactive HPA axis or hypercortisolemia. Hypercortisolism can result in the depletion of spleen, thymic, and lymphoid tissues, impaired cytokine production, and a widespread suppression of cellular immunity. Stress-induced hypercortisolism is counteracted by compensatory inhibition of cortisol's immunoregulatory effects, leading to a reduction in the levels of cortisol [293]. Additionally, the influence of cortisol on target tissues may be modulated by cortisol-induced downregulation of the HPA axis and by glucocorticoid receptor (GR) activity. Moreover, hypocortisolism and GR resistance are reciprocally associated with increased inflammatory activity and subsequent tissue damage [294].
Diverse studies have proposed links between oral health, the immune system, and several psychosocial factors [295]. Specifically, psychosocial stress has been associated with poorer oral health, although the exact psychophysiological mechanisms underlying this connection remain broadly unclear [296]. The direct immuno-neuroendocrine influence was underlined by changes in several salivary biomarkers (e.g., TNF-α, IL-6, IL-1β, α-amylase) of healthy individuals after specific psychological conditions. This implies a direct biochemical impact of psychosocial factors on the oral ecosystem [297]. The psychosocial components of periodontitis have been extensively studied, with stress identified as a contributor to its initiation and development. Acute stress may impair cellular immunity, whereas prolonged stress results in systemic immune dysregulation. Salivary concentrations of β-endorphin and cortisol, along with psychological states like anxiety and depression, are linked to periodontal health outcomes [298].
A considerable amount of research has focused on the in vitro effects of stress-associated proteins and hormones, including adrenaline, noradrenaline, mucin, and cortisol, on OM alteration. For example, Roberts et al. [299] found that adrenaline and noradrenaline stimulated the growth of Campylobacter, Eikenella, and Actinomyces and suppressed the growth of Bacteroides forsythus and P. gingivalis isolated from the subgingival microbial complex. In addition, cortisol, adrenaline, and noradrenaline substantially diminished the growth of F. nucleatum after 12 hours of treatment [300]. In contrast, the growth of the periodontal pathogen Porphyromonas endodontalis was suppressed after treatment with cortisol, adrenaline, and noradrenaline for 24 hours, although no inhibitory effects were noted in the case of P. intermedia and P. gingivalis [300]. Changes in the gene expression profiles of the microbiome, resembling those seen in periodontitis, were detected through a metatranscriptomic analysis of samples obtained from dental plaque exposed to cortisol [281]. These authors reported that Leptotrichia goodfellowii, belonging to the phylum Fusobacteriota, presented a substantially greater abundance of transcripts in the plaque samples treated with cortisol. However, the response of other members of this phylum, such as F. nucleatum, to stress-related proteins and hormones is very different. Although mucin, a salivary protein linked to stress, has been shown to enhance the viability of F. nucleatum, cortisol did not seem to influence this bacterium [301].
The role that psychological stress plays in OM has been investigated in several clinical studies. For example, Nani et al. [302] examined the connections between salivary bacteria, oral emissions of volatile sulfur compounds, and academic-associated persistent stress. The main findings of these authors were that the academic-associated persistent stress enhanced salivary Solobacterium moorei levels. S. moorei showed a correlation with F. nucleatum, which in turn was linked to hydrogen sulfide levels in the stress group, contributing to halitosis. Differential salivary microbiota diversity in relation to the affective state was found by Kohn et al. [303]. The high-stress group exhibited greater α-diversity compared to the low-stress group. The taxa most strongly linked to host distress encompassed Haemophilus, Selenomonas, and Leptotrichia, whereas the taxa with the weakest association were predominantly from the genus Prevotella. Israeli veterans diagnosed with post-traumatic stress disorder (PTSD) following participation in the Lebanon War exhibited OM dysbiosis, and decreased bacterial species (Alloprevotella spp., Caprocytophaga spp., and Selenomonas noxia) were correlated with PTSD severity, including intrusiveness, arousal, and reactivity, as well as with other psychopathological symptoms such as memory impairments, idiopathic pain, hostility, and anxiety. Similarly, in a study on Israeli veterans of the 1982 Lebanon War with PTSD symptoms, Levert-Levitt et al. [304] reported that a specific microbiota signature (i.e., decreased levels of the bacteria sp_HMT_914, 332, and 871, as well as S. noxia, alongside an increase in members of the phylum Bacteroidota) correlated with PTSD severity. This correlation was observed in relation to symptoms of arousal, intrusiveness, and reactivity, as well as additional psychopathological manifestations, including anxiety, hostility, idiopathic pain, and memory impairment. An overall increase in bacterial species richness was found at the end of a training week for military medical students [305], and several different bacterial taxa were identified from the beginning to the end of data collection, including the genera Corynebacterium, Eikenella, Tannerella, Rothia, Capnocytophaga, Leptotrichia, Haemophilus, Stomatobaculum, Aggregatibacter, and Porphyromonas, and also members of the families Actinomycetaceae and Pasteurellaceae.
More recently, groups of pregnant women with high and low PTSD symptoms differed in β-diversity, indicating variations in OM composition [306]. Discriminant analysis revealed differentially abundant microbiota between women experiencing high stress and low life stress, as well as those with PTSD. Specifically, members of the phylum Pseudomonadota were more prevalent in women with high recent life stress, and the genus Eikenella was increased with high PTSD. Finally, Charalambous et al. [307] examined the interplay between OM and the stress response in a cohort of adults who either experienced institutionalization and adoption or were non-adopted controls. The authors identified the following 12 bacterial taxa: Absconditabacteriales, Acinetobacter, Clostridia UCG14, Campylobacter, Cardiobacterium, Oxalobacteraceae, Sphingomonas, Bradyrhizobium, Comamonadaceae, Flavobacterium, Methylobrubrum, and Paucibacter, which interacted with the host cortisol and glucose response to stress and strongly influenced the clearance and intensity of cortisol and glucose after exposure to stress. Evidence indicates that exposure to high levels of cortisol leads to upregulation of virulence factors (LPS, fimbriae, or gingipains) in the periodontitis-related bacterial taxa Fusobacterium and Poprhymonas, leading to a global change in the composition toward a pathogenic type [198],[308],[309]. This capacity of OM to adapt to the hormonal response of the host is partially attributed to resilience mechanisms that determine the community composition and drive homeostasis [6]. During HPA activation and stress response, catecholamines are released in addition to cortisol. Several studies have reported that these stress hormones can foster or suppress the growth of oral microbiota associated with periodontitis; while it is clear that stress induces taxonomic shifts in the composition of OM [6],[310], the directionality of the interaction remains unclear. The OM has been shown to be implicated in the modulation of neurological processes, shaping cognition and behavior via interaction with the neuroendocrine system [198]. This modulation could partly result from metabolites or other small molecules released by OM and absorbed by the host [311].
Bipolar disorder (BD) is a psychiatric condition marked by significant mood fluctuations, including manic or hypomanic episodes and also periods of depression [312]. Patients with BD typically have deficient oral hygiene, which may be linked to low self-care, alcohol consumption, smoking, and the side effects of psychotropic drugs. Potential mechanisms that explain this connection include the influence of inflammatory mediators, modulation of the neurotransmitter system, direct impact of OM, and interactions with the vagus nerve and with the HPA axis [313]. Research on the relationship between BD and OM remains limited. Cunha et al. [314] found that BD is related to an increased risk of periodontitis, a greater prevalence of microbial pathogens, and an elevated bacterial load, including species such as A. actinomycetemcomitans and P. gingivalis. The increased prevalence of periodontitis and the bacterial load for A. actinomycetemcomitans and P. gingivalis were particularly pronounced during depressive phases, as compared to manic or euthymic phases [314].
Schizophrenia is a chronic mental disorder encompassing three symptom categories: (i) positive symptoms such as delusions, hallucinations, and disorganized thinking; (ii) negative symptoms such as emotional flattening, diminished affect, and social withdrawal; and (iii) cognitive symptoms such as difficulties with learning and attention [315]. Research has shown that periodontal disease causes neuroinflammation by releasing inflammatory cytokines within the CNS and by stimulating immune and microglial cells, potentially being implicated in the mechanism by which inflammation influences schizophrenia [316]. Compared to the controls, patients with schizophrenia have a distinct microbial composition based on α- and β-diversity, and these differences are linked to symptom severity [317]. Interestingly, it has been noted that oral metabolism disorders arise prior to the development of schizophrenia and are implicated in its pathogenesis via the peripheral inflammatory response and redox system [318]. An imbalance in the OM in saliva may also lead to the pathogenesis of schizophrenia by inducing oxidative stress, dysregulated tyrosine metabolism, peripheral inflammation, and BBB permeability [318]. Regarding the composition of OM, several review studies have been conducted. Castro-Nallar et al. [319] found differences between both groups (PWS and HC) at phylum and genus levels, with the fungi phylum Ascomycota being more abundant in PWS than HC. Lactic acid bacteria were relatively more abundant in PWS, including species of lactobacilli, bifidobacteria, and Eubacterium halii, which have been shown to modulate chronic inflammation. Dickerson et al. [320], in a review study, reported that among 25 differentially abundant microbial species (bacteria and fungi), 6 were significantly more prevalent in schizophrenia cases compared to controls after adjusting for relevant covariates. Lactic acid bacteria, such as Lactobacillus and Bifidobacterium, were notably enriched in schizophrenia, with Lactobacillus gasseri being 400 times more abundant in patients than in controls. Yolken et al. [321] found an altered β-diversity in PWS and mania as compared to HC and reported that the oropharyngeal microbiota of PWS and subjects with mania differed from HC. Three of the taxa, Prevotella, Weeksellaceae, and N. subflava, were reduced in PWS or mania in comparison to that of controls, while streptococci were increased in these groups. Furthermore, Qing et al. [322] found that the salivary microbiome of PWS was marked by greater α-diversity and lower β-diversity heterogeneity than that of controls. In addition, Pseudomonadota, the predominant phylum, was depleted, while Bacillota and the Bacillota/Pseudomonadota ratio were enriched from controls to schizophrenic patients. H2S-producing bacteria showed enrichment specific to disease stages and may serve as potential diagnostic biomarkers for schizophrenia. More recently, several studies have suggested that components of the OM could serve as potential diagnostic biomarkers for schizophrenia. For example, Ling et al. [323] reported that schizophrenia-associated oral dysbiosis, characterized by increased levels of Streptococcus and Fusobacterium, and decreased levels of Prevotella and Veillonella, may act as a potential biomarker for schizophrenia. Furthermore, an elevated Streptococcus/Prevotella ratio could indicate oral dysbiosis, with associations to immunological profiles, as well as lipid and amino acid metabolism. Regarding oral fungal communities, Liu et al. [324] identified two distinct mycotypes in schizophrenia patients: one showing an increase in the genus Malassezia and the other showing reduced Candida levels. Moreover, schizophrenia patients exhibited signs of immunological dysfunction, characterized by elevated levels of pro-inflammatory cytokines such as IL-6 and TNF-α, and chemokines such as MIP-1α and MCP-1. Notably, the Malassezia mycotype was positively correlated with peripheral pro-inflammatory cytokines, while the Candida mycotype showed a negative correlation with these cytokines.
Down's syndrome (DS) is a genetic disorder characterized by mild to moderate intellectual disability and distinct facial features. DS is also associated with specific oral characteristics, including a decreased prevalence of dental caries but an increased prevalence of periodontitis and gingivitis when compared to controls. Nevertheless, the overall composition of OM in individuals with DS, as well as how it varies with various factors such as host age or oral pH, remain insufficiently explored [325]. Although several studies have shown that the DS population develops earlier and more extensive periodontal destruction, Reuland-Bosma et al. [326] reported an absence of specific microbiota in adults with DS compared to controls. Despite this result, Amano et al. [327] identified P. gingivalis involved in gingival inflammation and plaque accumulation in individuals with DS; also, salivary S. mutans was higher in children and adolescents with DS and mental retardation than in controls [328]. Khocht et al. [329] reported that the prevalence of periodontal bacterial pathogens in individuals with DS may vary depending on age. The subgingival microbiological profiles of adults with DS and periodontitis resemble those found in individuals with chronic periodontitis. Specifically, Prevotella nigrescens, Peptostreptococcus micros, and E. corrodens are substantially more prevalent in young adults with DS, while P. gingivalis, A. actinomycetemcomitans, C. rectus, P. intermedia, and C. sputigena are more common during adolescence. In addition, Actinomyces naeslundi and T. forsythia are consistently found in individuals with DS, regardless of age. These authors also noted notable distinctions between the groups for certain bacterial species, including T. forsythia, P. intermedia, A. actinomycetemcomitans, P. gingivalis, S. noxia, C. acnes, S. oralis, S. gordonii, S. mitis, Treponema socranskii, and S. constellatus. However, the majority of detected bacteria are opportunistic, indicating that factors such as hand contamination (e.g., finger biting or thumb sucking) may play a role. More recently, Willis et al. [330] reported that DS is linked to lower salivary pH and a reduced OM diversity, characterized by lower levels of Atopobium, Alloprevotella, and Candidatus Saccharimonas aalborgensis, as well as by higher levels of Gemella, Kingella, Staphylococcus, Cardiobacterium, Actinobacillus, and Rothia, along with a greater prevalence of Candida parapsilosis and Candida dubliniensis. However, other authors have reported that the taxonomic analysis of OM showed notable differences in the relative abundance levels of specific bacteria between the DS and non-DS groups. Cuenca et al. [331] studied various periodontal conditions, including 62 cases of DS-periodontal health, 34 cases of DS-gingivitis, and 28 cases of DS-periodontitis. T. forsythia was the most prevalent species in all groups, with significantly higher percentages in DS-periodontitis compared to DS-gingivitis and DS-periodontal health. Furthermore, the frequency detection, counts, and proportions of P. gingivalis, P. intermedia, T. forsythia, and E. corrodens showed a progressive increase that correlated with the deterioration of periodontal status. In addition, Mitsuhata et al. [332] found that children with DS do not exhibit red complex microorganisms (P. gingivalis, T. forsythia, and T. denticola) but have a unique OM that may influence the development of dental diseases common in children with the syndrome, characterized by the presence of Corynebacterium, Abiotrophia, and Lautropia. However, other studies indicate that the oral bacterial composition in individuals with DS may resemble that of non-syndromic individuals with periodontitis [333]. Conversely, once periodontitis is present, the subgingival microbiota of subjects with DS shows a greater abundance of Porphyromonas, Treponema, Aggregatibacter, and Tannerella, along with a lower abundance of genera such as Filifactor, Fretibacterium, and Desulfobulbus, suggesting a microbial profile analogous to that found in non-syndromic individuals affected by periodontitis [334]. Previously, it was noted that the prevalence of periodontal bacterial pathogens may vary with the age of individuals with DS. Peptostreptococcus micros, P. nigrescens, and E. corrodens are significantly more prevalent in young adults with DS, while C. rectus, A. actinomycetemcomitans, P. gingivalis, P. intermedia, and C. sputigena are more commonly found during adolescence. Furthermore, T. forsythia and A. naeslundi are consistently observed in subjects with DS across all age groups.
Children with cerebral palsy and epilepsy are also affected by periodontitis and dental caries. In fact, clinical research indicates that up to 86% of children diagnosed with cerebral palsy have mild-to-moderate gingivitis [335], and a similar percentage have dental caries [336]. One study found decreased levels of Bacillota and Bacteroidota, alongside elevated levels of Actinomycetota, in the mouth of children with cerebral palsy and epilepsy compared to healthy children [337]. A comparative analysis of the supragingival plaque microbiota in children with cerebral palsy and severe caries versus those without cerebral palsy and severe caries showed a higher abundance of P. intermedia, Fusobacterium nucleatum, C. rectus, P. endodontalis, Streptobacillus moniliformis, Catonella morbi, Parvimonas micra, Porphyromonas canoris, and Alloprevotella tannerae in the former group. These bacteria may contribute to the pathogenesis of cerebral palsy via the oral–gut–brain axis [338]. Compared to individuals without epilepsy, epileptic subjects present heightened α-diversity in their OM, alongside significant β-diversity differences between the groups. In this regard, epileptic patients have a marked increase in the abundance of 26 genera, such as Kluyvera, Granulicatella, and Streptococcus, while experiencing a substantial reduction in 14 genera, including Schaalia, Neisseria, and Peptostreptococcus [339]. A recent Mendelian randomized analysis in East Asian children with epilepsy was conducted by Zhao et al. [340]. These authors found that 14 oral microbial taxa, such as S. mitis, S. pneumoniae, and Haemophilus spp., were positively associated with epilepsy, while members of the genera Fusobacterium and Aggregatibacter were negatively related to epilepsy.
The World Health Organization considers oral health as a key indicator of overall health, well-being, and quality of life. Besides, it states that oral health shares modifiable risk factors with the leading non-communicable diseases, such as cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, or autoimmune diseases, to name a few [341]. In recent decades, several studies have supported the significant role of the OM and the oral–gut–brain axis in the etiology and development of various psychological and psychiatric disorders [188],[190]. While the influence of OM on mental health requires further clarification, oral health is acknowledged as a pivotal factor in overall well-being and quality of life [342]. Oral diseases can profoundly impact the functional and psychosocial dimensions of individuals [343], leading to a diminished quality of life in those affected by common dental conditions [344],[345], as well as in patients with malignant diseases such as oral cancer [346].
The use of next-generation sequencing methods has led to important advances in the study of the microbiome in the human body [347]. From a clinical and human health perspective, OM, in addition to causing oral diseases, will become a new focus. In this regard, the importance of OM management has increased due to the growing aging population, improved medical treatment prognosis, and infection control in immunocompromised patients [348]. Nevertheless, there is still exiguous evidence on the identification of OM for disease prevention and health promotion. In this review, we have highlighted the involvement of specific oral pathogenic bacteria in systemic diseases [142] and mental health [189]. Thus, it is plausible to state that OM play a pivotal role in both oral and systemic health, including mental health, and that it is potentially influenced by diverse factors such as diet, age, genetics, drug consumption, and other environmental exposures, which shape its composition and diversity. Although primarily studied for its local effects, growing evidence suggests the significant impact of OM on brain health. Direct and indirect related pathways provide potential routes through which the OM can influence neuroinflammation, disrupt the BBB, and contribute to altered cognitive function. Regarding this, certain oral pathogens have been shown to invade the bloodstream and affect neuronal processes. Specifically, changes in OM may lead to gut dysbiosis, which in turn leads to low-grade inflammation in the gut and elevated permeability of biological barriers, including the BBB [195]. Neuroinflammation and cognitive impairment seem to be derived factors of OM dysbiosis based on the results revealed in various studies [196],[197]. Moreover, oral pathogens such as P. gingivalis lead to an “oralization” of the gut microbiota [349],[350], a mechanism that causes gut inflammation and may be related to the emergence and maintenance of neuroinflammation [194],[351] via the translocation of oral/intestinal toxic bacterial proteases to the brain [188],[352]. Therefore, substances with anti-inflammatory properties may help to ameliorate the development or alleviate the symptoms of certain mental disorders [353]. It has been stated that a high intake of docosahexaenoic acid (DHA) may provide neuroprotection during the early stages of the onset of dementia-related cognitive deficits [354]. In the same vein, several components of vegetarian diets and fermented vegetables, such as the fatty acids of long-chain ω-3 derivatives and plant polyphenols, including resveratrol, have been associated with beneficial effects on brain health [355]. Ribeiro-Vidal et al. [356] examined the in vitro antimicrobial properties of two ω-3 fatty acids, DHA and eicosapentaenoic acid (EPA), on a subgingival biofilm. The findings indicate that DHA and EPA significantly reduced the harmful bacterial strains contemplated, such as F. nucleatum, P. gingivalis, A. actinomycetemcomitans, and V. parvula. However, this study used an in vitro model, and randomized controlled trials are needed to ensure the beneficial properties of these substances on oral pathogens and mental health. In addition, plant polyphenols, such as anthocyanins, have shown beneficial effects in preventing and ameliorating certain clinical manifestations of progressive AD [357],[358]. In addition, polyphenols have been suggested as potential therapeutic agents in the treatment of oral infectious diseases [359],[360]. Another approach to control and reduce inflammation is the use of antimicrobial peptides, which can affect oral cavity homeostasis through the broad or selective killing of bacterial pathogens and through their immunomodulatory properties, which can impact both the innate and adaptive immune response [361].
Although several other therapeutic tools have been used for oral diseases, including probiotic, prebiotic, synbiotic, and postbiotic treatment [362], as well as photodynamic [363], quorum quenching [364], and phage therapy [365], to date these treatments have been hardly applied in mental health related to oral microorganisms. Maitre et al. [366] reported a limited development concerning the use of prebiotics and/or probiotics for modulating OM dysbiosis, which may be implicated in the onset and progression of mental disorders. Therefore, more efforts need to be made in the future to find an effective treatment for mental disorders associated with oral pathogens, as exemplified by the use of psychobiotics within the context of gut dysbiosis, which have been applied in the treatment of adverse mental states such as stress, anxiety, and depression through the modulation of the gut microbiome [367].
Furthermore, it is worth highlighting an important psychosocial aspect of the relationship between oral and mental health, which extends beyond physiological factors. Poor oral health and visible dental issues can contribute to social rejection in interpersonal interactions, with the level of visibility being a key factor in the intensity of discrimination. While dental problems are directly visible, bad breath, although not seen, can still provoke strong negative reactions in close proximity. This dynamic can be likened to the stigma associated with skin conditions, such as acne or psoriasis, which are also linked to microbiome dysbiosis and can contribute to a major risk of bullying victimization and social rejection [368]. In this respect, given that individuals with lower socioeconomic status often experience poorer oral health [75], this situation could exacerbate the risk and severity of social exclusion, creating a compounded disadvantage for them.
As with any study of this nature, the present narrative review is subject to various limitations, as follows: (i) The oral cavity contains multiple ecological niches, each characterized by distinct microbial communities, contributing to the considerable diversity of OM. This inherent complexity makes it challenging to draw definitive conclusions. (ii) It is important to note that the studies included in this review primarily focus on bacterial communities. However, emerging research on the oral mycobiome and viral communities indicates that these microorganisms may also play a pivotal role in the regulation of OM homeostasis. (iii) Several of the studies reviewed are cross-sectional or exploratory, with small sample sizes, thus complicating the establishment of causal relationships between the examined factors. (iv) A significant limitation across the studies is the lack of standardized protocols for sample collection, sequencing, and data analysis, which impedes meaningful comparisons of results across different investigations. (v) Finally, the considerable variability in sequencing technologies and molecular techniques employed complicates the interpretation and comparison of findings across studies.
A substantial body of evidence indicates that gut microbiota dysbiosis plays a role in the onset and progression of various mental disorders. In contrast, research on the microbiota of other host-associated sites, such as the oral cavity, remains relatively underexplored. Investigating OM is particularly important, given its potential to interact with the gut microbiota via multiple pathways within the intestinal tract, as well as its direct influence on brain functions via the trigeminal nerve and olfactory system. The complex balance of syntrophic and antagonistic interactions within OM, along with processes like horizontal gene transfer, underscores the need for a metabolomic approach to fully understand its diversity and functionality. This highlights the importance of considering a wide range of factors, particularly those related to diet and lifestyle, when examining the determinants that shape OM and its potential impact on overall health. Chronic oral diseases can impair the oral mucosal barrier, allowing microorganisms and endotoxins to enter the bloodstream, triggering systemic inflammation and affecting the BBB. This pathway can lead to neuroinflammation and cognitive dysfunction and contribute to the onset and development of mental health conditions. Additionally, OM may influence brain function through the translocation of oral bacteria to the gut, driving persistent inflammation and thereby affecting brain health. Multiple studies suggest a potential relationship between OM and various mental and neurodegenerative disorders, such as AD, PD, anxiety, and depression. However, further research is needed to strengthen the evidence surrounding these associations and to fully clarify the underlying mechanisms linking OM to these conditions. Given the promising implications, future research should focus on elucidating the biological mechanisms through which alterations in OM influence the development and progression of determinate neurodegenerative and neuropsychiatric disorders. Additionally, identifying reliable biomarkers linked to OM could enhance early detection, diagnosis, and monitoring of these conditions. There is considerable promise in microbiota-targeted interventions, such as plant-based diets, probiotics, prebiotics, synbiotics, microbiome-derived metabolites, and fecal microbiota transplantation, for the treatment and prevention of these disorders. Furthermore, longitudinal research tracking changes in OM and their associations with brain-related conditions will be pivotal for translating microbiota-based interventions into clinical applications, marking a significant advancement within this field.
The authors declare they have not used Artificial Intelligence (AI) tools in the creation of this article.
[1] |
Mark Welch JL, Ramírez-Puebla ST, Borisy GG (2020) Oral microbiome geography: Micron-scale habitat and niche. Cell Host Microbe 28: 160-168. https://doi.org/10.1016/j.chom.2020.07.009 ![]() |
[2] |
Cho YD, Kim KH, Lee YM, et al. (2021) Oral microbiome and host health: Review on current advances in genome-wide analysis. Appl Sci 11: 4050. https://doi.org/10.3390/app11094050 ![]() |
[3] |
Chowdhry A, Kapoor P, Bhargava D, et al. (2023) Exploring the oral microbiome: An updated multidisciplinary oral healthcare perspective. Discoveries 11: e165. https://doi.org/10.15190/d.2023.4 ![]() |
[4] |
Gao L, Xu T, Huang G, et al. (2018) Oral microbiomes: More and more importance in oral cavity and whole body. Protein Cell 9: 488-500. https://doi.org/10.1007/s13238-018-0548-1 ![]() |
[5] |
Spatafora G, Li Y, He X, et al. (2024) The evolving microbiome of dental caries. Microorganisms 12: 121. https://doi.org/10.3390/microorganisms12010121 ![]() |
[6] |
Cornejo Ulloa P, van der Veen MH, Krom BP (2019) Review: Modulation of the oral microbiome by the host to promote ecological balance. Odontology 107: 437-448. https://doi.org/10.1007/s10266-019-00413-x ![]() |
[7] |
Bacali C, Vulturar R, Buduru S, et al. (2022) Oral microbiome: Getting to know and befriend neighbors, a biological approach. Biomedicines 10: 671. https://doi.org/10.3390/biomedicines10030671 ![]() |
[8] |
Dethlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449: 811-818. https://doi.org/10.1038/nature06245 ![]() |
[9] |
Bäumler AJ, Sperandio V (2016) Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535: 85-93. https://doi.org/10.1038/nature18849 ![]() |
[10] |
Honda K, Littman DR (2016) The microbiota in adaptive immune homeostasis and disease. Nature 535: 75-84. https://doi.org/10.1038/nature18848 ![]() |
[11] |
Thaiss CA, Zmora N, Levy M, et al. (2016) The microbiome and innate immunity. Nature 535: 65-74. https://doi.org/10.1038/nature18847 ![]() |
[12] |
Kilian M (2018) The oral microbiome-friend or foe?. Eur J Oral Sci 126: 5-12. https://doi.org/10.1111/eos.12527 ![]() |
[13] | Integrative HMP (iHMP) Research Network Consortium.The integrative human microbiome project. Nature (2019) 569: 641-648. https://doi.org/10.1038/s41586-019-1238-8 |
[14] |
Escapa IF, Chen T, Huang Y, et al. (2018) New insights into human nostril microbiome from the expanded Human Oral Microbiome Database (eHOMD): A resource for the microbiome of the human aerodigestive tract. mSystems 3: e00187-18. https://doi.org/10.1128/mSystems.00187-18 ![]() |
[15] |
Verma D, Garg PK, Dubey AK (2018) Insights into the human oral microbiome. Arch Microbiol 200: 525-540. https://doi.org/10.1007/s00203-018-1505-3 ![]() |
[16] |
Shi H, Shi Q, Grodner B, et al. (2020) Highly multiplexed spatial mapping of microbial communities. Nature 588: 676-681. https://doi.org/10.1038/s41586-020-2983-4 ![]() |
[17] |
Van't Hof W, Veerman EC, Nieuw Amerongen AV, et al. (2014) Antimicrobial defense systems in saliva. Monogr Oral Sci 24: 40-51. https://doi.org/10.1159/000358783 ![]() |
[18] |
Sultan AS, Kong EF, Rizk AM, et al. (2018) The oral microbiome: A lesson in coexistence. PLoS Pathog 14: e1006719. https://doi.org/10.1371/journal.ppat.1006719 ![]() |
[19] |
Camanocha A, Dewhirst FE (2014) Host-associated bacterial taxa from Chlorobi, Chloroflexi, GN02, Synergistetes, SR1, TM7, and WPS-2 Phyla/candidate divisions. J Oral Microbiol 6: 10.3402/jom.v6.25468. https://doi.org/10.3402/jom.v6.25468 ![]() |
[20] |
Campbell JH, O'Donoghue P, Campbell AG, et al. (2013) UGA is an additional glycine codon in uncultured SR1 bacteria from the human microbiota. Proc Natl Acad Sci U S A 110: 5540-5545. https://doi.org/10.1073/pnas.1303090110 ![]() |
[21] |
Fernandes CdC, Rechenberg DK, Zehnder M, et al. (2014) Identification of Synergistetes in endodontic infections. Microb Pathog 73: 1-6. https://doi.org/10.1016/j.micpath.2014.05.001 ![]() |
[22] |
Murugkar PP, Collins AJ, Chen T, et al. (2020) Isolation and cultivation of candidate phyla radiation Saccharibacteria (TM7) bacteria in coculture with bacterial hosts. J Oral Microbiol 12: 1814666. https://doi.org/10.1080/20002297.2020.1814666 ![]() |
[23] |
Aleksandrowicz P, Brzezińska-Błaszczyk E, Dudko A, et al. (2020) Archaea occurrence in the subgingival biofilm in patients with peri-implantitis and periodontitis. Int J Periodontics Restorative Dent 40: 677-683. https://doi.org/10.11607/prd.4670 ![]() |
[24] |
Dame-Teixeira N, de Cena JA, Côrtes DA, et al. (2020) Presence of Archaea in dental caries biofilms. Arch Oral Biol 110: 104606. https://doi.org/10.1016/j.archoralbio.2019.104606 ![]() |
[25] | Santacroce L, Sardaro N, Topi S, et al. (2020) The pivotal role of oral microbiota in health and disease. J Biol Regul Homeost Agents 34: 733-737. https://doi.org/10.23812/20-127-L-45 |
[26] |
Hong BY, Hoare A, Cardenas A, et al. (2020) The salivary mycobiome contains 2 ecologically distinct mycotypes. J Dent Res 99: 730-738. https://doi.org/10.1177/0022034520915879 ![]() |
[27] |
Peters BA, Wu J, Hayes RB, et al. (2017) The oral fungal mycobiome: Characteristics and relation to periodontitis in a pilot study. BMC Microbiol 17: 157. https://doi.org/10.1186/s12866-017-1064-9 ![]() |
[28] |
Caselli E, Fabbri C, D'Accolti M, et al. (2020) Defining the oral microbiome by whole-genome sequencing and resistome analysis: The complexity of the healthy picture. BMC Microbiol 20: 120. https://doi.org/10.1186/s12866-020-01801-y ![]() |
[29] |
Morán-Torres A, Pazos-Salazar NG, Téllez-Lorenzo S, et al. (2021) HPV oral and oropharynx infection dynamics in young population. Braz J Microbiol 52: 1991-2000. https://doi.org/10.1007/s42770-021-00602-3 ![]() |
[30] |
Syrjanen S (2018) Oral manifestations of human papillomavirus infections. Eur J Oral Sci 126: 49-66. https://doi.org/10.1111/eos.12538 ![]() |
[31] |
Atyeo N, Rodriguez MD, Papp B, et al. (2021) Clinical manifestations and epigenetic regulation of oral herpesvirus infections. Viruses 13: 681. https://doi.org/10.3390/v13040681 ![]() |
[32] |
Crimi S, Fiorillo L, Bianchi A, et al. (2019) Herpes virus, oral clinical signs and QoL: Systematic review of recent data. Viruses 11: 463. https://doi.org/10.3390/v11050463 ![]() |
[33] |
Polvora TLS, Nobre AVV, Tirapelli C, et al. (2018) Relationship between human immunodeficiency virus (HIV-1) infection and chronic periodontitis. Expert Rev Clin Immunol 14: 315-327. https://doi.org/10.1080/1744666X.2018.1459571 ![]() |
[34] |
Xiao X, Liu S, Deng H, et al. (2023) Advances in the oral microbiota and rapid detection of oral infectious diseases. Front Microbiol 14: 1121737. https://doi.org/10.3389/fmicb.2023.1121737 ![]() |
[35] |
Banar M, Rokaya D, Azizian R, et al. (2024) Oral bacteriophages: Metagenomic clues to interpret microbiomes. Peer J 12: e16947. https://doi.org/10.7717/peerj.16947 ![]() |
[36] |
Edlund A, Santiago-Rodriguez TM, Boehm TK, et al. (2015) Bacteriophage and their potential roles in the human oral cavity. J Oral Microbiol 7: 27423. https://doi.org/10.3402/jom.v7.27423 ![]() |
[37] |
Szafrański SP, Slots J, Stiesch M (2021) The human oral phageome. Periodontol. 2000 86: 79-96. https://doi.org/10.1111/prd.12363 ![]() |
[38] |
Pride DT, Salzman J, Haynes M, et al. (2012) Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J 6: 915-926. https://doi.org/10.1038/ismej.2011.169 ![]() |
[39] |
Yaseen A, Mahafzah A, Dababseh D, et al. (2021) Oral colonization by Entamoeba gingivalis and Trichomonas tenax: A PCR-based study in health, gingivitis, and periodontitis. Front Cell Infect Microbiol 11: 782805. https://doi.org/10.3389/fcimb.2021.782805 ![]() |
[40] |
Dewhirst FE, Chen T, Izard J, et al. (2010) The human oral microbiome. J Bacteriol 192: 5002-5017. https://doi.org/10.1128/JB.00542-10 ![]() |
[41] |
Seidel CL, Gerlach RG, Wiedemann P, et al. (2020) Defining metaniches in the oral cavity according to their microbial composition and cytokine profile. Int J Mol Sci 21: 8218. https://doi.org/10.3390/ijms21218218 ![]() |
[42] |
Asakawa M, Takeshita T, Furuta M, et al. (2018) Tongue microbiota and oral health status in community-dwelling elderly adults. mSphere 3: e00332-18. https://doi.org/10.1128/mSphere.00332-18 ![]() |
[43] |
Camelo-Castillo AJ, Mira A, Pico A, et al. (2015) Subgingival microbiota in health compared to periodontitis and the influence of smoking. Front Microbiol 6: 119. https://doi.org/10.3389/fmicb.2015.00119 ![]() |
[44] |
Espinoza JL, Harkins DM, Torralba M, et al. (2018) Supragingival plaque microbiome ecology and functional potential in the context of health and disease. mBio 9: e01631-18. https://doi.org/10.1128/mBio.01631-18 ![]() |
[45] |
Inquimbert C, Bourgeois D, Bravo M, et al. (2019) The oral bacterial microbiome of interdental surfaces in adolescents according to carious risk. Microorganisms 7: 319. https://doi.org/10.3390/microorganisms7090319 ![]() |
[46] |
Lee YH, Chung SW, Auh QS, et al. (2021) Progress in oral microbiome related to oral and systemic diseases: An update. Diagnostics 11: 1283. https://doi.org/10.3390/diagnostics11071283 ![]() |
[47] |
Li X, Liu Y, Yang X, et al. (2022) The oral microbiota: Community composition, influencing factors, pathogenesis, and interventions. Front Microbiol 13: 895537. https://doi.org/10.3389/fmicb.2022.895537 ![]() |
[48] |
Zhang Y, Wang X, Li H, et al. (2018) Human oral microbiota and its modulation for oral health. Biomed Pharmacother 99: 883-893. https://doi.org/10.1016/j.biopha.2018.01.146 ![]() |
[49] |
Shi W, Tian J, Xu H, et al. (2018) Distinctions and associations between the microbiota of saliva and supragingival plaque of permanent and deciduous teeth. PLoS One 13: e0200337. https://doi.org/10.1371/journal.pone.0200337 ![]() |
[50] |
Murugesan S, Al Ahmad SF, Singh P, et al. (2020) Profiling the salivary microbiome of the Qatari population. J Transl Med 18: 127. https://doi.org/10.1186/s12967-020-02291-2 ![]() |
[51] |
Takeshita T, Kageyama S, Furuta M, et al. (2016) Bacterial diversity in saliva and oral health-related conditions: The Hisayama study. Sci Rep 6: 22164. https://doi.org/10.1038/srep22164 ![]() |
[52] |
Shaw L, Ribeiro ALR, Levine AP, et al. (2017) The human salivary microbiome is shaped by shared environment rather than genetics: Evidence from a large family of closely related individuals. mBio 8: e01237-17. https://doi.org/10.1128/mBio.01237-17 ![]() |
[53] |
Lynge Pedersen AM, Belstrøm D (2019) The role of natural salivary defences in maintaining a healthy oral microbiota. J Dent 80: S3-S12. https://doi.org/10.1016/j.jdent.2018.08.010 ![]() |
[54] |
Fábián TK, Hermann P, Beck A, et al. (2012) Salivary defense proteins: Their network and role in innate and acquired oral immunity. Int J Mol Sci 13: 4295-4320. https://doi.org/10.3390/ijms13044295 ![]() |
[55] |
Ren W, Zhang Q, Liu X, et al. (2017) Exploring the oral microflora of preschool children. J Microbiol 55: 531-537. https://doi.org/10.1007/s12275-017-6474-8 ![]() |
[56] |
Costalonga M, Herzberg MC (2014) The oral microbiome and the immunobiology of periodontal disease and caries. Immunol Lett 162: 22-38. https://doi.org/10.1016/j.imlet.2014.08.017 ![]() |
[57] |
Simón-Soro A, Tomás I, Cabrera-Rubio R, et al. (2013) Microbial geography of the oral cavity. J Dent Res 92: 616-621. https://doi.org/10.1177/0022034513488119 ![]() |
[58] |
Takeshita T, Yasui M, Shibata Y, et al. (2015) Dental plaque development on a hydroxyapatite disk in young adults observed by using a barcoded pyrosequencing approach. Sci Rep 5: 8136. https://doi.org/10.1038/srep08136 ![]() |
[59] |
Roberts AP, Kreth J (2014) The impact of horizontal gene transfer on the adaptive ability of the human oral microbiome. Front Cell Infect Microbiol 4: 124. https://doi.org/10.3389/fcimb.2014.00124 ![]() |
[60] |
Kolenbrander PE, Palmer RJ, Periasamy S, et al. (2010) Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8: 471-480. https://doi.org/10.1038/nrmicro2381 ![]() |
[61] |
Chen Y, Li Y, Zou J (2019) Intrageneric and intergeneric interactions developed by oral streptococci: Pivotal role in the pathogenesis of oral diseases. Curr Issues Mol Biol 32: 377-434. https://doi.org/10.21775/cimb.032.377 ![]() |
[62] |
Bowen WH, Burne RA, Wu H, et al. (2018) Oral biofilms: Pathogens, matrix, and polymicrobial interactions in microenvironments. Trends Microbiol 26: 229-242. https://doi.org/10.1016/j.tim.2017.09.008 ![]() |
[63] |
Heller D, Helmerhorst EJ, Oppenheim FG (2017) Saliva and serum protein exchange at the tooth enamel surface. J Dent Res 96: 437-443. https://doi.org/10.1177/0022034516680771 ![]() |
[64] |
Mohammed WK, Krasnogor N, Jakubovics NS (2018) Streptococcus gordonii challisin protease is required for sensing cell-cell contact with Actinomyces oris. FEMS Microbiol Ecol 94: fiy043. https://doi.org/10.1093/femsec/fiy043 ![]() |
[65] |
Mutha NVR, Mohammed WK, Krasnogor N, et al. (2018) Transcriptional responses of Streptococcus gordonii and Fusobacterium nucleatum to coaggregation. Mol Oral Microbiol 33: 450-464. https://doi.org/10.1111/omi.12248 ![]() |
[66] |
Takahashi N (2015) Oral microbiome metabolism: From "Who are they?" to "What are they doing?". J Dent Res 94: 1628-1637. https://doi.org/10.1177/0022034515606045 ![]() |
[67] |
Zhou P, Manoil D, Belibasakis GN, et al. (2021) Veillonellae: Beyond bridging species in oral biofilm ecology. Front Oral Health 2: 774115. https://doi.org/10.3389/froh.2021.774115 ![]() |
[68] |
Kriebel K, Hieke C, Muller-Hilke B, et al. (2018) Oral biofilms from symbiotic to pathogenic interactions and associated disease-Connection of periodontitis and rheumatic arthritis by peptidylarginine deiminase. Front Microbiol 9: 53. https://doi.org/10.3389/fmicb.2018.00053 ![]() |
[69] |
Brennan CA, Garrett WS (2019) Fusobacterium nucleatum-Symbiont, opportunist and oncobacterium. Nat Rev Microbiol 17: 156-166. https://doi.org/10.1038/s41579-018-0129-6 ![]() |
[70] |
Lima BP, Shi W, Lux R (2017) Identification and characterization of a novel Fusobacterium nucleatum adhesin involved in physical interaction and biofilm formation with Streptococcus gordonii. Microbiologyopen 6: e00444. https://doi.org/10.1002/mbo3.444 ![]() |
[71] |
Lima BP, Hu LI, Vreeman GW, et al. (2019) The oral bacterium Fusobacterium nucleatum binds Staphylococcus aureus and alters expression of the staphylococcal accessory regulator sarA. Microb Ecol 78: 336-347. https://doi.org/10.1007/s00248-018-1291-0 ![]() |
[72] |
Jayaraman A, Wood TK (2008) Bacterial quorum sensing: Signals, circuits, and implications for biofilms and disease. Annu Rev Biomed Eng 10: 145-167. https://doi.org/10.1146/annurev.bioeng.10.061807.160536 ![]() |
[73] |
Li YH, Tian X (2012) Quorum sensing and bacterial social interactions in biofilms. Sensors 12: 2519-2538. https://doi.org/10.3390/s120302519 ![]() |
[74] |
Santacroce L, Passarelli PC, Azzolino D, et al. (2023) Oral microbiota in human health and disease: A perspective. Exp Biol Med 248: 1288-1301. https://doi.org/10.1177/15353702231187645 ![]() |
[75] |
Belstrøm D, Holmstrup P, Nielsen CH, et al. (2014) Bacterial profiles of saliva in relation to diet, lifestyle factors, and socioeconomic status. J Oral Microbiol 6: 10.3402/jom.v6.23609. https://doi.org/10.3402/jom.v6.23609 ![]() |
[76] |
Dagli N, Dagli R, Darwish S, et al. (2016) Oral microbial shift: Factors affecting the microbiome and prevention of oral disease. J Contemp Dent Pract 17: 90-96. https://doi.org/10.5005/jp-journals-10024-1808 ![]() |
[77] |
Menon RK, Gomez A, Brandt BW, et al. (2019) Long-term impact of oral surgery with or without amoxicillin on the oral microbiome-A prospective cohort study. Sci Rep 9: 18761. https://doi.org/10.1038/s41598-019-55056-3 ![]() |
[78] |
Larsson Wexell C, Ryberg H, Sjöberg Andersson WA, et al. (2016) Antimicrobial effect of a single dose of amoxicillin on the oral microbiota. Clin Implant Dent Relat Res 18: 699-706. https://doi.org/10.1111/cid.12357 ![]() |
[79] |
Moraes LC, Lang PM, Arcanjo RA, et al. (2020) Microbial ecology and predicted metabolic pathways in various oral environments from patients with acute endodontic infections. Int Endod J 53: 1603-1617. https://doi.org/10.1111/iej.13389 ![]() |
[80] |
Raju SC, Viljakainen H, Figueiredo RAO, et al. (2020) Antimicrobial drug use in the first decade of life influences saliva microbiota diversity and composition. Microbiome 8: 121. https://doi.org/10.1186/s40168-020-00893-y ![]() |
[81] |
Almeida VSM, Azevedo J, Leal HF, et al. (2020) Bacterial diversity and prevalence of antibiotic resistance genes in the oral microbiome. PLoS One 15: e0239664. https://doi.org/10.1371/journal.pone.0239664 ![]() |
[82] |
Oba PM, Holscher HD, Mathai RA, et al. (2020) Diet influences the oral microbiota of infants during the first six months of life. Nutrients 12: 3400. https://doi.org/10.3390/nu12113400 ![]() |
[83] |
Chumponsuk T, Gruneck L, Gentekaki E, et al. (2021) The salivary microbiota of Thai adults with metabolic disorders and association with diet. Arch Oral Biol 122: 105036. https://doi.org/10.1016/j.archoralbio.2020.105036 ![]() |
[84] |
Yussof A, Yoon P, Krkljes C, et al. (2020) A meta-analysis of the effect of binge drinking on the oral microbiome and its relation to Alzheimer's disease. Sci Rep 10: 19872. https://doi.org/10.1038/s41598-020-76784-x ![]() |
[85] |
Nociti FH, Casati MZ, Duarte PM (2015) Current perspective of the impact of smoking on the progression and treatment of periodontitis. Periodontol 2000 67: 187-210. https://doi.org/10.1111/prd.12063 ![]() |
[86] |
Wu J, Peters BA, Dominianni C, et al. (2016) Cigarette smoking and the oral microbiome in a large study of American adults. ISME J 10: 2435-2446. https://doi.org/10.1038/ismej.2016.37 ![]() |
[87] |
Senaratne NLM, Yung On C, Shetty NY, et al. (2024) Effect of different forms of tobacco on the oral microbiome in healthy adults: A systematic review. Front Oral Health 5: 1310334. https://doi.org/10.3389/froh.2024.1310334 ![]() |
[88] |
Lin W, Jiang W, Hu X, et al. (2018) Ecological shifts of supragingival microbiota in association with pregnancy. Front Cell Infect Microbiol 8: 24. https://doi.org/10.3389/fcimb.2018.00024 ![]() |
[89] |
Fujiwara N, Tsuruda K, Iwamoto Y, et al. (2017) Significant increase of oral bacteria in the early pregnancy period in Japanese women. J Investig Clin Dent 8: e12189. https://doi.org/10.1111/jicd.12189 ![]() |
[90] |
Li H, Xiao B, Zhang Y, et al. (2019) Impact of maternal intrapartum antibiotics on the initial oral microbiome of neonates. Pediatr Neonatol 60: 654-661. https://doi.org/10.1016/j.pedneo.2019.03.011 ![]() |
[91] |
Gao J, Wang H, Li Z, et al. (2018) Candida albicans gains azole resistance by altering sphingolipid composition. Nat Commun 9: 4495. https://doi.org/10.1038/s41467-018-06944-1 ![]() |
[92] |
Monroy-Pérez E, Rodríguez-Bedolla RM, Garzón J, et al. (2020) Marked virulence and azole resistance in Candida albicans isolated from patients with periodontal disease. Microb Pathog 148: 104436. https://doi.org/10.1016/j.micpath.2020.104436 ![]() |
[93] |
Sweeney EL, Al-Shehri SS, Cowley DM, et al. (2018) The effect of breastmilk and saliva combinations on the in vitro growth of oral pathogenic and commensal microorganisms. Sci Rep 8: 15112. https://doi.org/10.1038/s41598-018-33519-3 ![]() |
[94] |
Anderson AC, Rothballer M, Altenburger MJ, et al. (2020) Long-term fluctuation of oral biofilm microbiota following different dietary phases. Appl Environ Microbiol 86: e0142120. https://doi.org/10.1128/AEM.01421-20 ![]() |
[95] |
Hansen TH, Kern T, Bak EG, et al. (2018) Impact of a vegan diet on the human salivary microbiota. Sci Rep 8: 5847. https://doi.org/10.1038/s41598-018-24207-3 ![]() |
[96] |
Štšepetova J, Truu J, Runnel R, et al. (2019) Impact of polyols on oral microbiome of Estonian schoolchildren. BMC Oral Health 19: 60. https://doi.org/10.1186/s12903-019-0747-z ![]() |
[97] |
Sanchez MC, Ribeiro-Vidal H, Esteban-Fernandez A, et al. (2019) Antimicrobial activity of red wine and oenological extracts against periodontal pathogens in a validated oral biofilm model. BMC Complement Altern Med 19: 145. https://doi.org/10.1186/s12906-019-2533-5 ![]() |
[98] |
Jia YJ, Liao Y, He YQ, et al. (2021) Association between oral microbiota and cigarette smoking in the Chinese population. Front Cell Infect. Microbiol 11: 658203. https://doi.org/10.3389/fcimb.2021.658203 ![]() |
[99] |
Yu G, Phillips S, Gail MH, et al. (2017) The effect of cigarette smoking on the oral and nasal microbiota. Microbiome 5: 3. https://doi.org/10.1186/s40168-016-0226-6 ![]() |
[100] |
Kumar PS, Matthews CR, Joshi V, et al. (2011) Tobacco smoking affects bacterial acquisition and colonization in oral biofilms. Infect Immun 79: 4730-4738. https://doi.org/10.1128/IAI.05371-11 ![]() |
[101] |
Al Bataineh MT, Dash NR, Elkhazendar M, et al. (2020) Revealing oral microbiota composition and functionality associated with heavy cigarette smoking. J Transl Med 18: 421. https://doi.org/10.1186/s12967-020-02579-3 ![]() |
[102] |
Yang Y, Zheng W, Cai QY, et al. (2019) Cigarette smoking and oral microbiota in low-income and African-American populations. J Epidemiol Community Health 73: 1108-1115. https://doi.org/10.1136/jech-2019-212474 ![]() |
[103] |
Saadaoui M, Singh P, Al Khodor S (2021) Oral microbiome and pregnancy: A bidirectional relationship. J Reprod Immunol 145: 103293. https://doi.org/10.1016/j.jri.2021.103293 ![]() |
[104] |
Barak S, Oettinger-Barak O, Oettinger M, et al. (2003) Common oral manifestations during pregnancy: A review. Obstet Gynecol Surv 58: 624-628. https://doi.org/10.1097/01.OGX.0000083542.14439.CF ![]() |
[105] |
Tettamanti L, Lauritano D, Nardone M, et al. (2017) Pregnancy and periodontal disease: Does exist a two-way relationship?. Oral Implantol 10: 112-118. https://doi.org/10.11138/orl/2017.10.2.112 ![]() |
[106] |
León R, Silva N, Ovalle A, et al. (2007) Detection of Porphyromonas gingivalis in the amniotic fluid in pregnant women with a diagnosis of threatened premature labor. J Periodontol 78: 1249-1255. https://doi.org/10.1902/jop.2007.060368 ![]() |
[107] |
Jang H, Patoine A, Wu TT, et al. (2021) Oral microflora and pregnancy: A systematic review and meta-analysis. Sci Rep 11: 16870. https://doi.org/10.1038/s41598-021-96495-1 ![]() |
[108] |
Pecci-Lloret MP, Linares-Pérez C, Pecci-Lloret MR, et al. (2024) Oral manifestations in pregnant women: A systematic review. J Clin Med 13: 707. https://doi.org/10.3390/jcm13030707 ![]() |
[109] |
Hurley E, Barrett MPJ, Kinirons M, et al. (2019) Comparison of the salivary and dentinal microbiome of children with severe-early childhood caries to the salivary microbiome of caries-free children. BMC Oral Health 19: 13. https://doi.org/10.1186/s12903-018-0693-1 ![]() |
[110] |
Wei Y, Shi M, Zhen M, et al. (2019) Comparison of subgingival and buccal mucosa microbiome in chronic and aggressive periodontitis: A pilot study. Front Cell Infect Microbiol 9: 53. https://doi.org/10.3389/fcimb.2019.00053 ![]() |
[111] |
Kim YT, Jeong J, Mun S, et al. (2022) Comparison of the oral microbial composition between healthy individuals and periodontitis patients in different oral sampling sites using 16S metagenome profiling. J Periodontal Implant Sci 52: 394-410. https://doi.org/10.5051/jpis.2200680034 ![]() |
[112] | Dipalma G, Inchingolo AD, Inchingolo F, et al. (2021) Focus on the cariogenic process: Microbial and biochemical interactions with teeth and oral environment. J Biol Regul Homeost Agents 35: 429-440. https://doi.org/10.23812/20-747-A |
[113] |
Belibasakis GN, Bostanci N, Marsh PD, et al. (2019) Applications of the oral microbiome in personalized dentistry. Arch Oral Biol 104: 7-12. https://doi.org/10.1016/j.archoralbio.2019.05.023 ![]() |
[114] |
Bek-Thomsen M, Tettelin H, Hance I, et al. (2008) Population diversity and dynamics of Streptococcus mitis, Streptococcus oralis, and Streptococcus infantis in the upper respiratory tracts of adults, determined by a nonculture strategy. Infect Immun 76: 1889-1896. https://doi.org/10.1128/IAI.01511-07 ![]() |
[115] |
López-López A, Camelo-Castillo A, Ferrer MD, et al. (2017) Health-associated niche inhabitants as oral probiotics: The case of Streptococcus dentisani. Front Microbiol 8: 379. https://doi.org/10.3389/fmicb.2017.00379 ![]() |
[116] |
Morou-Bermudez E, Rodriguez S, Bello AS, et al. (2015) Urease and dental plaque microbial profiles in children. PloS One 10: e0139315. https://doi.org/10.1371/journal.pone.0139315 ![]() |
[117] |
Reyes E, Martin J, Moncada G, et al. (2014) Caries-free subjects have high levels of urease and arginine deiminase activity. J Appl Oral Sci 22: 235-240. https://doi.org/10.1590/1678-775720130591 ![]() |
[118] | Tanner AC, Kressirer CA, Faller LL (2016) Understanding caries from the oral microbiome perspective. J Calif Dent Assoc 44: 437-446. |
[119] |
Ma C, Chen F, Zhang Y, et al. (2015) Comparison of oral microbial profiles between children with severe early childhood caries and caries-free children using the human oral microbe identification microarray. PLoS One 10: e0122075. https://doi.org/10.1371/journal.pone.0122075 ![]() |
[120] |
Wang Y, Zhang J, Chen X, et al. (2017) Profiling of oral microbiota in early childhood caries using single-molecule real-time sequencing. Front Microbiol 8: 2244. https://doi.org/10.3389/fmicb.2017.02244 ![]() |
[121] |
Agnello M, Marques J, Cen L, et al. (2017) Microbiome associated with severe caries in Canadian First Nations children. J Dent Res 96: 1378-1385. https://doi.org/10.1177/22034517718819 ![]() |
[122] |
Giordano-Kelhoffer B, Lorca C, March Llanes J, et al. (2022) Oral microbiota, its equilibrium and implications in the pathophysiology of human diseases: A systematic review. Biomedicines 10: 1803. https://doi.org/10.3390/biomedicines10081803 ![]() |
[123] |
Murakami S, Mealey BL, Mariotti A, et al. (2018) Dental plaque-induced gingival conditions. J Clin Periodontol 45: S17-S27. https://doi.org/10.1002/JPER.17-0095 ![]() |
[124] |
Van Dyke TE, Bgartold PM, Reynolds EC (2020) The nexus between periodontal inflammation and dysbiosis. Front Immunol 11: 511. https://doi.org/10.3389/fimmu.2020.00511 ![]() |
[125] |
Abusleme L, Dupuy AK, Dutzan N, et al. (2013) The subgingival microbiome in health and periodontitis and its relationship with community biomass and inflammation. ISME J 7: 1016-1025. https://doi.org/10.1038/ismej.2012.174 ![]() |
[126] |
Curtis MA, Diaz PI, Van Dyke TE (2020) The role of the microbiota in periodontal disease. Periodontol 83: 14-25. https://doi.org/10.1111/prd.12296 ![]() |
[127] |
Schincaglia GP, Hong BY, Rosania A, et al. (2017) Clinical, immune, and microbiome traits of gingivitis and peri-implant mucositis. J Dent Res 96: 47-55. https://doi.org/10.1177/0022034516668847 ![]() |
[128] |
Nowicki EM, Shroff R, Singleton JA, et al. (2018) Microbiota and metatranscriptome changes accompanying the onset of gingivitis. mBio 9: e00575-18. https://doi.org/10.1128/mBio.00575-18 ![]() |
[129] |
Contaldo M, Itro A, Lajolo C, et al. (2020) Overview of osteoporosis, periodontitis and oral dysbiosis: The emerging role of oral microbiota. Appl Sci 10: 6000. https://doi.org/10.3390/app10176000 ![]() |
[130] |
Scannapieco FA, Dongari-Bagtzoglou A (2021) Dysbiosis revisited: Understanding the role of the oral microbiome in the pathogenesis of gingivitis and periodontitis: A critical assessment. J Periodontol 92: 1071-1078. https://doi.org/10.1002/JPER.21-0120 ![]() |
[131] |
Holmstrup P, Damgaard C, Olsen I, et al. (2017) Comorbidity of oeriodontal diseases: Two sides of the same coin?. J Oral Microbiol 9: 1332710. https://doi.org/10.1080/20002297.2017.1332710 ![]() |
[132] |
Hajishengallis G, Chavakis T (2021) Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol 21: 426-440. https://doi.org/10.1038/s41577-020-00488-6 ![]() |
[133] |
Maitre Y, Mahalli R, Micheneau P, et al. (2021) Evidence and therapeutic perspectives in the relationship between the oral microbiome and Alzheimer's disease: A systematic review. Int J Environ Res Public Health 18: 11157. https://doi.org/10.3390/ijerph182111157 ![]() |
[134] |
Poole S, Singhrao SK, Kesavalu L, et al. (2013) Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer's disease brain tissue. J Alzheimers Dis 36: 665-677. https://doi.org/10.3233/JAD-121918 ![]() |
[135] |
Vila T, Sultan AS, Montelongo-Jauregui D, et al. (2020) Oral candidiasis: A disease of opportunity. J Fungi 6: 15. https://doi.org/10.3390/jof6010015 ![]() |
[136] |
Man A, Ciurea CN, Pasaroiu D, et al. (2017) New perspectives on the nutritional factors influencing growth rate of Candida albicans in diabetics. An in vitro study. Mem Inst Oswaldo Cruz 112: 587-592. https://doi.org/10.1590/0074-02760170098 ![]() |
[137] | Boorghani M, Gholizadeh N, Taghavi Zenouz A, et al. (2010) Oral lichen planus: Clinical features, etiology, treatment and management; a review of literature. J Dent Res Dent Clin Dent Prospect 4: 3-9. https://doi.org/10.5681/joddd.2010.002 |
[138] |
Bornstein MM, Hakimi B, Persson GRJ (2008) Microbiological findings in subjects with asymptomatic oral lichen planus: A cross-sectional comparative study. J Periodontol 79: 2347-2355. https://doi.org/10.1902/jop.2008.080303 ![]() |
[139] |
Ertugrul AS, Arslan U, Dursun R, et al. (2013) Periodontopathogen profile of healthy and oral lichen planus patients with gingivitis or periodontitis. Int J Oral Sci 5: 92-97. https://doi.org/10.1038/ijos.2013.30 ![]() |
[140] |
Choi YS, Kim Y, Yoon HJ, et al. (2016) The presence of bacteria within tissue provides insights into the pathogenesis of oral lichen planus. Sci Rep 6: 29186. https://doi.org/10.1038/srep29186 ![]() |
[141] |
Yan L, Xu J, Lou F, et al. (2024) Alterations of oral microbiome and metabolic signatures and their interaction in oral lichen planus. J Oral Microbiol 16: 2422164. https://doi.org/10.1080/20002297.2024.2422164 ![]() |
[142] |
Thomas C, Minty M, Vinel A, et al. (2021) Oral microbiota: A major player in the diagnosis of systemic diseases. Diagnostics 11: 1376. https://doi.org/10.3390/diagnostics11081376 ![]() |
[143] |
Bourgeois D, Inquimbert C, Ottolenghi L, et al. (2019) Periodontal pathogens as risk factors of cardiovascular diseases, diabetes, rheumatoid arthritis, cancer, and chronic obstructive pulmonary disease-Is there cause for consideration?. Microorganisms 7: 424. https://doi.org/10.3390/microorganisms7100424 ![]() |
[144] |
Chopra A, Franco-Duarte R, Rajagopal A, et al. (2024) Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data. Sci Rep 14: 1476. https://doi.org/10.1038/s41598-023-50891-x ![]() |
[145] |
Corrêa JD, Calderaro DC, Ferreira GA, et al. (2017) Subgingival microbiota dysbiosis in systemic lupus erythematosus: Association with periodontal status. Microbiome 5: 34. https://doi.org/10.1186/s40168-017-0252-z ![]() |
[146] | Yan X, Yang M, Liu J, et al. (2015) Discovery and validation of potential bacterial biomarkers for lung cancer. Am J Cancer Res 5: 3111-3122. |
[147] |
Liu WJ, Xiao M, Yi J, et al. (2019) First case report of bacteremia caused by Solobacterium moorei in China, and literature review. BMC Infect Dis 19: 730. https://doi.org/10.1186/s12879-019-4359-7 ![]() |
[148] |
Flemer B, Warren RD, Barrett MP, et al. (2018) The oral microbiota in colorectal cancer is distinctive and predictive. Gut 67: 1454-1463. https://doi.org/10.1136/gutjnl-2017-314814 ![]() |
[149] |
Keogh RA, Doran KS (2023) Group B Streptococcus and diabetes: Finding the sweet spot. PLoS Pathog 19: e1011133. https://doi.org/10.1371/journal.ppat.1011133 ![]() |
[150] |
Martini AM, Moricz BS, Ripperger AK, et al. (2020) Association of novel Streptococcus sanguinis virulence factors with pathogenesis in a native valve infective endocarditis model. Front Microbiol 11: 10. https://doi.org/10.3389/fmicb.2020.00010 ![]() |
[151] |
Hammad MI, Conrads G, Abdelbary MMH (2023) Isolation, identification, and significance of salivary Veillonella spp., Prevotella spp., and Prevotella salivae in patients with inflammatory bowel disease. Front Cell Infect Microbiol 13: 1278582. https://doi.org/10.3389/fcimb.2023.1278582 ![]() |
[152] | Saladi L, Zeana C, Singh M (2017) Native valve endocarditis due to Veillonella species: A case report and review of the literature. Case Rep Infect Dis 2017: 4896186. https://doi.org/10.1155/2017/4896186 |
[153] |
Zhan Z, Liu W, Pan L, et al. (2022) Overabundance of Veillonella parvula promotes intestinal inflammation by activating macrophages via LPS-TLR4 pathway. Cell Death Discov 8: 251. https://doi.org/10.1038/s41420-022-01015-3 ![]() |
[154] |
Ganesan SM, Joshi V, Fellows M, et al. (2017) A tale of two risks: Smoking, diabetes and the subgingival microbiome. ISME J 11: 2075-2089. https://doi.org/10.1038/ismej.2017.73 ![]() |
[155] |
Eriksson K, Fei G, Lundmark A, et al. (2019) Periodontal health and oral microbiota in patients with rheumatoid arthritis. J Clin Med 8: 630. https://doi.org/10.3390/jcm8050630 ![]() |
[156] |
Gnanasekaran J, Binder Gallimidi A, Saba E, et al. (2020) Intracellular Porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells. Cancers 12: 2331. https://doi.org/10.3390/cancers12082331 ![]() |
[157] |
Huang X, Li Y, Zhang J, et al. (2024) Linking periodontitis with inflammatory bowel disease through the oral-gut axis: The potential role of Porphyromonas gingivalis. Biomedicines 12: 685. https://doi.org/10.3390/biomedicines12030685 ![]() |
[158] |
Jia S, Li X, Du Q (2023) Host insulin resistance caused by Porphyromonas gingivalis - Review of recent progresses. Front Cell Infect Microbiol 13: 1209381. https://doi.org/10.3389/fcimb.2023.1209381 ![]() |
[159] |
Li Y, Guo R, Oduro PK, et al. (2022) The relationship between Porphyromonas gingivalis and rheumatoid arthritis: A meta-analysis. Front Cell Infect Microbiol 12: 956417. https://doi.org/10.3389/fcimb.2022.956417 ![]() |
[160] |
Malinowski B, Węsierska A, Zalewska K, et al. (2019) The role of Tannerella forsythia and Porphyromonas gingivalis in pathogenesis of esophageal cancer. Infect Agents Cancer 14: 3. https://doi.org/10.1186/s13027-019-0220-2 ![]() |
[161] |
Reyes L, Phillips P, Wolfe B, et al. (2017) Porphyromonas gingivalis and adverse pregnancy outcome. J Oral Microbiol 10: 1374153. https://doi.org/10.1080/20002297.2017.1374153 ![]() |
[162] |
Stanisic D, Jeremic N, Singh M, et al. (2023) Porphyromonas gingivalis induces cardiovascular dysfunction. Can J Physiol Pharmacol 101: 413-424. https://doi.org/10.1139/cjpp-2022-0392 ![]() |
[163] |
Drago L (2019) Prevotella copri and microbiota in rheumatoid arthritis: Fully convincing evidence?. J Clin Med 8: 1837. https://doi.org/10.3390/jcm8111837 ![]() |
[164] |
Guo J, Cui G, Huang W, et al. (2023) Alterations in the human oral microbiota in systemic lupus erythematosus. J Transl Med 21: 95. https://doi.org/10.1186/s12967-023-03892-3 ![]() |
[165] |
Suzuki J, Imai Y, Aoki M, et al. (2014) Periodontitis in cardiovascular disease patients with or without Marfan syndrome-A possible role of Prevotella intermedia. PLoS One 9: e95521. https://doi.org/10.1371/journal.pone.0095521 ![]() |
[166] |
Yuan H, Wu X, Wang X, et al. (2024) Microbial dysbiosis linked to metabolic dysfunction-associated fatty liver disease in Asians: Prevotella copri promotes lipopolysaccharide biosynthesis and network instability in the Prevotella enterotype. Int J Mol Sci 25: 2183. https://doi.org/10.3390/ijms25042183 ![]() |
[167] |
Ardila CM, Perez-Valencia AY, Rendon-Osorio WL (2015) Tannerella forsythia is associated with increased levels of atherogenic low density lipoprotein and total cholesterol in chronic periodontitis. J Clin Expl Dent 7: e254-e260. https://doi.org/10.4317/jced.52128 ![]() |
[168] |
Martínez-Rivera JI, Xibillé-Friedmann DX, González-Christen J, et al. (2017) Salivary ammonia levels and Tannerella forsythia are associated with rheumatoid arthritis: A cross sectional study. Clin Exp Dent Res 3: 107-114. https://doi.org/10.1002/cre2.68 ![]() |
[169] | Schara R, Skaleric E, Seme K, et al. (2013) Prevalence of periodontal pathogens and metabolic control of type 1 diabetes patients. J Int Acad Periodontol 15: 29-34. |
[170] | Dhaliwal D, Bhargava R, Movahed MR (2023) Fusobacterium nucleatum endocarditis: A case report and literature review. Am J Cardiovasc Dis 13: 29-31. |
[171] |
Ghosh A, Jaaback K, Boulton A, et al. (2024) Fusobacterium nucleatum: An overview of evidence, demi-decadal trends, and its role in adverse pregnancy outcomes and various gynecological diseases, including cancers. Cells 13: 717. https://doi.org/10.3390/cells13080717 ![]() |
[172] |
Luo L, Tang J, Du X, et al. (2024) Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians. Respir Med 225: 107586. https://doi.org/10.1016/j.rmed.2024.107586 ![]() |
[173] |
Matsha T, Prince Y, Davids S, et al. (2020) Oral microbiome signatures in diabetes mellitus and periodontal disease. J Dent Res 99: 658-665. https://doi.org/10.1177/0022034520913818 ![]() |
[174] |
Su W, Chen Y, Cao P, et al. (2020) Fusobacterium nucleatum promotes the development of ulcerative colitis by inducing the autophagic cell death of intestinal epithelial. Front Cell Infect Microbiol 10: 594806. https://doi.org/10.3389/fcimb.2020.594806 ![]() |
[175] |
Zepeda-Rivera M, Minot SS, Bouzek H, et al. (2024) A distinct Fusobacterium nucleatum clade dominates the colorectal cancer niche. Nature 628: 424-432. https://doi.org/10.1038/s41586-024-07182-w ![]() |
[176] |
Castrillon CA, Hincapie JP, Yepes FL, et al. (2015) Occurrence of red complex microorganisms and Aggregatibacter actinomycetemcomitans in patients with diabetes. J Invest Clin Dent 6: 25-31. https://doi.org/10.1111/jicd.12051 ![]() |
[177] |
Fan X, Alekseyenko AV, Wu J, et al. (2018) Human oral microbiome and prospective risk for pancreatic cancer: A population-based nested case-control study. Gut 67: 120-127. https://doi.org/10.1136/gutjnl-2016-312580 ![]() |
[178] |
Santana PT, Rosas SLB, Ribeiro BE, et al. (2022) Dysbiosis in inflammatory bowel disease: Pathogenic role and potential therapeutic targets. Int J Mol Sci 23: 3464. https://doi.org/10.3390/ijms23073464 ![]() |
[179] |
Talapko J, Juzbašić M, Meštrović T, et al. (2024) Aggregatibacter actinomycetemcomitans: From the oral cavity to the heart valves. Microorganisms 12: 1451. https://doi.org/10.3390/microorganisms12071451 ![]() |
[180] |
Thomas C, Minty M, Canceill T, et al. (2021) Obesity drives an oral microbiota signature of female patients with periodontitis: A pilot study. Diagnostics 11: 745. https://doi.org/10.3390/diagnostics11050745 ![]() |
[181] |
Zhang L, Lee H, Grimm MC, et al. (2014) Campylobacter concisus and inflammatory bowel disease. World J Gastroenterol 20: 1259-1267. https://doi.org/10.3748/wjg.v20.i5.1259 ![]() |
[182] |
Short B, Carson S, Devlin AC, et al. (2021) Non-typeable Haemophilus influenzae chronic colonization in chronic obstructive pulmonary disease (COPD). Crit Rev Microbiol 47: 192-205. https://doi.org/10.1080/1040841X.2020.1863330 ![]() |
[183] |
Murphy TF, Brauer AL, Pettigrew MM, et al. (2019) Persistence of Moraxella catarrhalis in chronic obstructive pulmonary disease and regulation of the Hag/MID adhesin. J Infect Dis 219: 1448-1455. https://doi.org/10.1093/infdis/jiy680 ![]() |
[184] |
Borrego-Ruiz A, Borrego JJ (2024) An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders. Prog Neuropsychopharmacol Biol Psychiatry 128: 110861. https://doi.org/10.1016/j.pnpbp.2023.110861 ![]() |
[185] |
Hashimoto K (2023) Emerging role of the host microbiome in neuropsychiatric disorders: Overview and future directions. Mol Psychiatry 28: 3625-3637. https://doi.org/10.1038/s41380-023-02287-6 ![]() |
[186] |
Martin CR, Osadchiy V, Kalani A, et al. (2018) The brain-gut-microbiome axis. Cell Mol Gastroenterol Hepatol 6: 133-148. https://doi.org/10.1016/j.jcmgh.2018.04.003 ![]() |
[187] |
Tiwari T, Kelly A, Randall CL, et al. (2022) Association between mental health and oral health status and care utilization. Front Oral Health 2: 732882. https://doi.org/10.3389/froh.2021.732882 ![]() |
[188] |
Maitre Y, Micheneau P, Delpierre A, et al. (2020) Did the brain and oral microbiota talk to each other? A review of the literature. J Clin Med 9: 3876. https://doi.org/10.3390/jcm9123876 ![]() |
[189] |
Skallevold HE, Rokaya N, Wongsirichat N, et al. (2023) Importance of oral health in mental health disorders: An updated review. J Oral Biol Craniofac Res 13: 544-552. https://doi.org/10.1016/j.jobcr.2023.06.003 ![]() |
[190] |
Tao K, Yuan Y, Xie Q, et al. (2024) Relationship between human oral microbiome dysbiosis and neuropsychiatric diseases: An updated overview. Behav Brain Res 471: 115111. https://doi.org/10.1016/j.bbr.2024.115111 ![]() |
[191] |
López-Valencia L, Moya M, Escudero B, et al. (2024) Bacterial lipopolysaccharide forms aggregates with apolipoproteins in male and female rat brains after ethanol binges. J Lipid Res 65: 100509. https://doi.org/10.1016/j.jlr.2024.100509 ![]() |
[192] |
Yu XC, Yang JJ, Jin BH, et al. (2017) A strategy for bypassing the blood-brain barrier: Facial intradermal brain-targeted delivery via the trigeminal nerve. J Control Release 258: 22-33. https://doi.org/10.1016/j.jconrel.2017.05.001 ![]() |
[193] |
Narengaowa, Kong W, Lan F, et al. (2021) The oral-gut-brain axis: The influence of microbes in Alzheimer's disease. Front Cell Neurosci 15: 633735. https://doi.org/10.3389/fncel.2021.633735 ![]() |
[194] |
Martínez M, Martín-Hernández D, Virto L, et al. (2021) Periodontal diseases and depression: A pre-clinical in vivo study. J Clin Periodontol 48: 503-527. https://doi.org/10.1111/jcpe.13420 ![]() |
[195] |
Ding Y, Ren J, Yu H, et al. (2018) Porphyromonas gingivalis, a periodontitis causing bacterium, induces memory impairment and age-dependent neuroinflammation in mice. Immun Ageing 15: 6. https://doi.org/10.1186/s12979-017-0110-7 ![]() |
[196] |
Bowman GL, Dayon L, Kirkland R, et al. (2018) Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults. Alzheimers Dement 14: 1640-1650. https://doi.org/10.1016/j.jalz.2018.06.2857 ![]() |
[197] |
Solár P, Zamani A, Kubíčková L, et al. (2020) Choroid plexus and the blood-cerebrospinal fluid barrier in disease. Fluids Barriers CNS 17: 35. https://doi.org/10.1186/s12987-020-00196-2 ![]() |
[198] |
Bowland GB, Weyrich LS (2022) The oral-microbiome-brain axis and neuropsychiatric disorders: An anthropological perspective. Front Psychiatry 13: 810008. https://doi.org/10.3389/fpsyt.2022.810008 ![]() |
[199] |
Bulgart HR, Neczypor EW, Wold LE, et al. (2020) Microbial involvement in Alzheimer disease development and progression. Mol Neurodegen 15: 42. https://doi.org/10.1186/s13024-020-00378-4 ![]() |
[200] | Liu Y, Wu Z, Zhang X, et al. (2013) Leptomeningeal cells transduce peripheral macrophages inflammatory signal to microglia in reponse to Porphyromonas gingivalis LPS. Mediators Inflamm 2013: 407562. https://doi.org/10.1155/2013/407562 |
[201] |
Sansores-España LD, Melgar-Rodríguez S, Olivares-Sagredo K, et al. (2021) Oral-gut-brain axis in experimental models of periodontitis: Associating gut dysbiosis with neurodegenerative diseases. Front Aging 2: 781582. https://doi.org/10.3389/fragi.2021.781582 ![]() |
[202] |
Schmidt TS, Hayward MR, Coelho LP, et al. (2019) Extensive transmission of microbes along the gastrointestinal tract. eLife 8: e42693. https://doi.org/10.7554/eLife.42693 ![]() |
[203] |
Atarashi K, Suda W, Luo C, et al. (2017) Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation. Science 358: 359-365. https://doi.org/10.1126/science.aan4526 ![]() |
[204] |
Kitamoto S, Nagao-Kitamoto H, Hein R, et al. (2020) The bacterial connection between the oral cavity and the gut diseases. J Dent Res 99: 1021-1029. https://doi.org/10.1177/0022034520924633 ![]() |
[205] |
Arimatsu K, Yamada H, Miyazawa H, et al. (2014) Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota. Sci Rep 4: 4828. https://doi.org/10.1038/srep04828 ![]() |
[206] |
Feng YK, Wu QL, Peng YW, et al. (2020) Oral P. gingivalis impairs gut permeability and mediates immune responses associated with neurodegeneration in LRRK2 R1441G mice. J Neuroinflammation 17: 347. https://doi.org/10.1186/s12974-020-02027-5 ![]() |
[207] |
Xue L, Zou X, Yang XQ, et al. (2020) Chronic periodontitis induces microbiota-gut-brain axis disorders and cognitive impairment in mice. Exp Neurol 326: 113176. https://doi.org/10.1016/j.expneurol.2020.113176 ![]() |
[208] |
Liao C, Rolling T, Djukovic A, et al. (2024) Oral bacteria relative abundance in faeces increases due to gut microbiota depletion and is linked with patient outcomes. Nat Microbiol 9: 1555-1565. https://doi.org/10.1038/s41564-024-01680-3 ![]() |
[209] |
Costa CFFA, Correia-de-Sá T, Araujo R, et al. (2024) The oral-gut microbiota relationship in healthy humans: Identifying shared bacteria between environments and age groups. Front Microbiol 15: 1475159. https://doi.org/10.3389/fmicb.2024.1475159 ![]() |
[210] |
Kageyama S, Sakata S, Ma J, et al. (2023) High-resolution detection of translocation of oral bacteria to the gut. J Dent Res 102: 752-758. https://doi.org/10.1177/00220345231160747 ![]() |
[211] |
Lu Y, Li Z, Peng X (2023) Regulatory effects of oral microbe on intestinal microbiota and the illness. Front Cell Infect Microbiol 13: 1093967. https://doi.org/10.3389/fcimb.2023.1093967 ![]() |
[212] |
Borrego-Ruiz A, Borrego JJ (2024) Influence of human gut microbiome on the healthy and the neurodegenerative aging. Exp Gerontol 194: 112497. https://doi.org/10.1016/j.exger.2024.112497 ![]() |
[213] |
Kamatham PT, Shukla R, Khatri DK, et al. (2024) Pathogenesis, diagnostics, and therapeutics for Alzheimer's disease: Breaking the memory barrier. Ageing Res Rev 101: 102481. https://doi.org/10.1016/j.arr.2024.102481 ![]() |
[214] |
Chen GF, Xu TH, Yan Y, et al. (2017) Amyloid beta: Structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38: 1205-1235. https://doi.org/10.1038/aps.2017.28 ![]() |
[215] |
Cerajewska TL, Davies M, West NX (2015) Periodontitis: A potential risk factor for Alzheimer's disease. Br Dent J 218: 29-34. https://doi.org/10.1038/sj.bdj.2014.1137 ![]() |
[216] |
Tuganbaev T, Yoshida K, Honda K (2022) The effects of oral microbiota on health. Science 376: 934-936. https://doi.org/10.1126/science.abn1890 ![]() |
[217] |
Wang RP, Ho YS, Leung WK, et al. (2019) Systemic inflammation linking chronic periodontitis to cognitive decline. Brain Behav Immun 81: 63-73. https://doi.org/10.1016/j.bbi.2019.07.002 ![]() |
[218] |
Tzeng NS, Chung CH, Yeh CB, et al. (2016) Are chronic periodontitis and gingivitis associated with dementia? A nationwide, retrospective, matched-cohort study in Taiwan. Neuroepidemiology 47: 82-93. https://doi.org/10.1159/000449166 ![]() |
[219] |
Chen CK, Wu YT, Chang YC (2017) Association between chronic periodontitis and the risk of Alzheimer's disease: A retrospective, population-based, matched-cohort study. Alzheimers Res Ther 9: 56. https://doi.org/10.1186/s13195-017-0282-6 ![]() |
[220] |
Dominy SS, Lynch C, Ermini F, et al. (2019) Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv 5: eaau3333. https://doi.org/10.1126/sciadv.aau3333 ![]() |
[221] |
Kunkle BW, Grenier-Boley B, Sims R, et al. (2019) Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet 51: 414-430. https://doi.org/10.1038/s41588-019-0358-2 ![]() |
[222] |
Kanagasingam S, von Ruhland C, Welbury R, et al. (2022) Porphyromonas gingivalis conditioned medium induces amyloidogenic processing of the amyloid-beta protein precursor upon in vitro infection of SH-SY5Y cells. J Alzheimers Dis Rep 6: 577-587. https://doi.org/10.3233/ADR-220029 ![]() |
[223] |
Jin R, Ning X, Liu X, et al. (2023) Porphyromonas gingivalis-induced periodontitis could contribute to cognitive impairment in Sprague-Dawley rats via the P38 MAPK signaling pathway. Front Cell Neurosci 17: 1141339. https://doi.org/10.3389/fncel.2023.1141339 ![]() |
[224] |
Morikawa T, Uehara O, Paudel D, et al. (2023) Systemic administration of lipopolysaccharide from Porphyromonas gingivalis decreases neprilysin expression in the mouse hippocampus. In Vivo 37: 163-172. https://doi.org/10.21873/invivo.13065 ![]() |
[225] |
Carpentier M, Robitaille Y, DesGroseillers L, et al. (2002) Declining expression of neprilysin in Alzheimer disease vasculature: Possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol 61: 849-856. https://doi.org/10.1093/jnen/61.10.849 ![]() |
[226] |
Grimm MO, Mett J, Stahlmann CP, et al. (2013) Neprilysin and Aβ clearance: Impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease. Front Aging Neurosci 5: 98. https://doi.org/10.3389/fnagi.2013.00098 ![]() |
[227] |
Jungbauer G, Stahli A, Zhu X, et al. (2022) Periodontal microorganisms and Alzheimer disease - A causative relationship?. Periodontol 2000 89: 59-82. https://doi.org/10.1111/prd.12429 ![]() |
[228] |
Díaz-Zúniga J, Munoz Y, Melgar-Rodríguez S, et al. (2019) Serotype b of Aggregatibacter actinomycetemcomitans triggers pro-inflammatory responses and amyloid beta secretion in hippocampal cells: A novel link between periodontitis and Alzheimeŕs disease?. J Oral Microbiol 11: 1586423. https://doi.org/10.1080/20002297.2019.1586423 ![]() |
[229] |
Holt SC, Ebersole JL (2005) Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: The “red complex”, a prototype polybacterial pathogenic consortium in periodontitis. Periodontol 2000 38: 72-122. https://doi.org/10.1111/j.1600-0757.2005.00113.x ![]() |
[230] |
Riviere GR, Riviere KH, Smith KS (2002) Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer's disease. Oral Microbiol Immunol 17: 113-118. https://doi.org/10.1046/j.0902-0055.2001.00100.x ![]() |
[231] |
Su X, Tang Z, Lu Z, et al. (2021) Oral Treponema denticola infection induces Aβ1-40 and Aβ1-42 accumulation in the hippocampus of C57BL/6 mice. J Mol Neurosci 71: 1506-1514. https://doi.org/10.1007/s12031-021-01827-5 ![]() |
[232] |
Wu L, Su X, Tang Z, et al. (2022) Treponema denticola induces neuronal apoptosis by promoting amyloid-beta accumulation in mice. Pathogens 11: 1150. https://doi.org/10.3390/pathogens11101150 ![]() |
[233] |
Yan C, Diao Q, Zhao Y, et al. (2022) Fusobacterium nucleatum infection-induced neurodegeneration and abnormal gut microbiota composition in Alzheimer's disease-like rats. Front Neurosci 16: 884543. https://doi.org/10.3389/fnins.2022.884543 ![]() |
[234] |
Wan J, Fan H (2023) Oral microbiome and Alzheimer's disease. Microorganisms 11: 2550. https://doi.org/10.3390/microorganisms11102550 ![]() |
[235] |
Watanabe I, Kuriyama N, Miyatani F, et al. (2016) Oral Cnm-positive Streptococcus mutans expressing collagen binding activity is a risk factor for cerebral microbleeds and cognitive impairment. Sci Rep 6: 38561. https://doi.org/10.1038/srep38561 ![]() |
[236] |
Wang DN, Hou XW, Yang BW, et al. (2015) Quantity of cerebral microbleeds, antiplatelet therapy, and intracerebral hemorrhage outcomes: A systematic review and meta-analysis. J Stroke Cerebrovasc Dis 24: 2728-2737. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.08.003 ![]() |
[237] |
Liu XX, Jiao B, Liao XX, et al. (2019) Analysis of salivary microbiome in patients with Alzheimer's disease. J Alzheimers Dis 72: 633-640. https://doi.org/10.3233/JAD-190587 ![]() |
[238] |
Wu YF, Lee WF, Salamanca E, et al. (2021) Oral microbiota changes in elderly patients, an indicator of Alzheimer's disease. Int J Environ Res Public Health 18: 4211. https://doi.org/10.3390/ijerph18084211 ![]() |
[239] |
Cirstea MS, Kliger D, MacLellan AD, et al. (2022) The oral and fecal microbiota in a Canadian cohort of Alzheimer's disease. J Alzheimers Dis 87: 247-258. https://doi.org/10.3233/JAD-215520 ![]() |
[240] |
Fu KL, Chiu MJ, Wara-Aswapati N, et al. (2023) Oral microbiome and serological analyses on association of Alzheimer's disease and periodontitis. Oral Dis 29: 3677-3687. https://doi.org/10.1111/odi.14348 ![]() |
[241] |
Issilbayeva A, Kaiyrlykyzy A, Vinogradova E, et al. (2024) Oral microbiome stamp in Alzheimer's disease. Pathogens 13: 195. https://doi.org/10.3390/pathogens13030195 ![]() |
[242] |
Holmer J, Aho V, Eriksdotter M, et al. (2021) Subgingival microbiota in a population with and without cognitive dysfunction. J Oral Microbiol 13: 1854552. https://doi.org/10.1080/20002297.2020.1854552 ![]() |
[243] |
Jankovic J, Tan EK (2020) Parkinson's disease: Etiopathogenesis and treatment. J Neurol Neurosurg Psychiatry 91: 795-808. https://doi.org/10.1136/jnnp-2019-322338 ![]() |
[244] |
Fleury V, Zekeridou A, Lazarevic V, et al. (2021) Oral dysbiosis and inflammation in Parkinson's disease. J Parkinsons Dis 11: 619-631. https://doi.org/10.3233/JPD-202459 ![]() |
[245] |
Rozas NS, Tribble GD, Jeter CB (2021) Oral factors that impact the oral microbiota in Parkinson's disease. Microorganisms 9: 1616. https://doi.org/10.3390/microorganisms9081616 ![]() |
[246] |
Bai XB, Xu S, Zhou LJ, et al. (2023) Oral pathogens exacerbate Parkinson's disease by promoting Th1 cell infiltration in mice. Microbiome 11: 254. https://doi.org/10.1186/s40168-023-01685-w ![]() |
[247] |
Jaber MA (2011) Dental caries experience, oral health status and treatment needs of dental patients with autism. J Appl Oral Sci 19: 212-217. https://doi.org/10.1590/s1678-77572011000300006 ![]() |
[248] | Ferrazzano GF, Salerno C, Bravaccio C, et al. (2020) Autism spectrum disorders and oral health status: Review of the literature. Eur J Paediatr Dent 21: 9-12. https://doi.org/10.23804/ejpd.2020.21.01.02 |
[249] |
Mussap M, Beretta P, Esposito E, et al. (2023) Once upon a time oral microbiota: A cinderella or a protagonist in Autism Spectrum Disorder?. Metabolites 13: 1183. https://doi.org/10.3390/metabo13121183 ![]() |
[250] |
Olsen I, Hicks SD (2019) Oral microbiota and autism spectrum disorder (ASD). J Oral Microbiol 12: 1702806. https://doi.org/10.1080/20002297.2019.1702806 ![]() |
[251] |
Kealy J, Greene C, Campbell M (2020) Blood-brain barrier regulation in psychiatric disorders. Neurosci Lett 726: 133664. https://doi.org/10.1016/j.neulet.2018.06.033 ![]() |
[252] |
Srikantha P, Mohajeri MH (2019) The possible role of the microbiota-gut-brain-axis in autism spectrum disorder. Int J Mol Sci 20: 2115. https://doi.org/10.3390/ijms20092115 ![]() |
[253] |
Tedjosasongko U, Oktaviani PD, Nadia S, et al. (2023) Can oral microbiome dysbiosis affect the behavior of children with Autism Spectrum Disorders (ASD)?: Narrative review. World J Adv Res Rev 17: 51-56. https://doi.org/10.30574/wjarr.2023.17.1.1461 ![]() |
[254] |
Johnson D, Letchumanan V, Thurairajasingam S, et al. (2020) A revolutionizing approach to autism spectrum disorder using the microbiome. Nutrients 12: 1983. https://doi.org/10.3390/nu12071983 ![]() |
[255] |
Hicks SD, Uhlig R, Afshari P, et al. (2018) Oral microbiome activity in children with autism spectrum disorder. Autism Res 11: 1286-1299. https://doi.org/10.1002/aur.1972 ![]() |
[256] |
Sivamaruthi BS, Suganthy N, Kesika P, et al. (2020) The role of microbiome, dietary supplements, and probiotics in autism spectrum disorder. Int J Environ Res Public Health 17: 2647. https://doi.org/10.3390/ijerph17082647 ![]() |
[257] |
Qiao Y, Wu M, Feng Y, et al. (2018) Alterations of oral microbiota distinguish children with autism spectrum disorders from healthy controls. Sci Rep 8: 1597. https://doi.org/10.1038/s41598-018-19982-y ![]() |
[258] |
Kong X, Liu J, Cetinbas M, et al. (2019) New and preliminary evidence on altered oral and gut microbiota in individuals with Autism Spectrum Disorder (ASD): Implications for ASD diagnosis and subtyping based on microbial biomarkers. Nutrients 11: 2128. https://doi.org/10.3390/nu11092128 ![]() |
[259] |
Abdulhaq A, Halboub E, Homeida HE, et al. (2021) Tongue microbiome in children with autism spectrum disorder. J Oral Microbiol 13: 1936434. https://doi.org/10.1080/20002297.2021.1936434 ![]() |
[260] |
Manghi P, Filosi M, Zolfo M, et al. (2024) Large-scale metagenomic analysis of oral microbiomes reveals markers for autism spectrum disorders. Nat Commun 15: 9743. https://doi.org/10.1038/s41467-024-53934-7 ![]() |
[261] |
Garbarino VR, Gilman TL, Daws LC (2019) Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol Res 140: 85-99. https://doi.org/10.1016/j.phrs.2018.07.010 ![]() |
[262] |
Evenepoel M, Daniels N, Moerkerke M, et al. (2024) Oral microbiota in autistic children: Diagnosis-related differences and associations with clinical characteristics. Brain Behav Immun Health 38: 100801. https://doi.org/10.1016/j.bbih.2024.100801 ![]() |
[263] |
Szuhany KL, Simon NM (2022) Anxiety disorders: A review. JAMA 328: 2431-2445. https://doi.org/10.1001/jama.2022.22744 ![]() |
[264] |
Johnson PL, Federici LM, Shekhar A (2014) Etiology, triggers and neurochemical circuits associated with unexpected, expected, and laboratory-induced panic attacks. Neurosci Biobehav Rev 46: 429-454. https://doi.org/10.1016/j.neubiorev.2014.07.027 ![]() |
[265] |
Krupa-Kotara K, Gwioździk W, Nandzik S, et al. (2023) The role of microbiota pattern in anxiety and stress disorders-A review of the state of knowledge. Psych 5: 602-618. https://doi.org/10.3390/psych5030038 ![]() |
[266] |
Nasir M, Trujillo D, Levine J, et al. (2020) Glutamate systems in DSM-5 anxiety disorders: Their role and a review of glutamate and GABA psychopharmacology. Front Psychiatry 11: 548505. https://doi.org/10.3389/fpsyt.2020.548505 ![]() |
[267] |
Hsu CC, Hsu YC, Chen HJ, et al. (2015) Association of periodontitis and subsequent depression: A nationwide population-based study. Medicine 94: e2347. https://doi.org/10.1097/MD.0000000000002347 ![]() |
[268] |
Malan-Müller S, Vidal R, O'Shea E, et al. (2024) Probing the oral-brain connection: Oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes. Transl Psychiatry 14: 419. https://doi.org/10.1038/s41398-024-03122-4 ![]() |
[269] |
Martínez M, Postolache TT, García-Bueno B, et al. (2022) The role of the oral microbiota related to periodontal diseases in anxiety, mood and trauma- and stress-related disorders. Front Psychiatry 12: 814177. https://doi.org/10.3389/fpsyt.2021.814177 ![]() |
[270] |
Xie Z, Jiang W, Deng M, et al. (2021) Alterations of oral microbiota in patients with panic disorder. Bioengineered 12: 9103-9112. https://doi.org/10.1080/21655979.2021.1994738 ![]() |
[271] |
Faravelli C, Lo Sauro C, Lelli L, et al. (2012) The role of life events and HPA axis in anxiety disorders: A review. Curr Pharm Des 18: 5663-5674. https://doi.org/10.2174/138161212803530907 ![]() |
[272] |
Juruena MF, Eror F, Cleare AJ, et al. (2020) The role of early life stress in HPA axis and anxiety. Adv Exp Med Biol 1191: 141-153. https://doi.org/10.1007/978-981-32-9705-0_9 ![]() |
[273] |
Simpson CA, Adler C, du Plessis MR, et al. (2020) Oral microbiome composition, but not diversity, is associated with adolescent anxiety and depression symptoms. Physiol Behav 226: 113126. https://doi.org/10.1016/j.physbeh.2020.113126 ![]() |
[274] |
Malhi GS, Mann JJ (2018) Depression. Lancet 392: 2299-2312. https://doi.org/10.1016/S0140-6736(18)31948-2 ![]() |
[275] | Bernard JER (2018) Depression: A review of its definition. MOJ Addict Med Ther 5: 6-7. https://doi.org/10.15406/mojamt.2018.05.00082 |
[276] |
Serafini RA, Pryce KD, Zachariou V (2020) The mesolimbic dopamine system in chronic pain and associated affective comorbidities. Biol Psychiatry 87: 64-73. https://doi.org/10.1016/j.biopsych.2019.10.018 ![]() |
[277] |
Moncrieff J, Cooper RE, Stockmann T, et al. (2023) The serotonin theory of depression: A systematic umbrella review of the evidence. Mol Psychiatry 28: 3243-3256. https://doi.org/10.1038/s41380-022-01661-0 ![]() |
[278] |
Daut RA, Fonken LK (2019) Circadian regulation of depression: A role for serotonin. Front Neuroendocrinol 54: 100746. https://doi.org/10.1016/j.yfrne.2019.04.003 ![]() |
[279] |
Peng GJ, Tian JS, Gao XX, et al. (2015) Research on the pathological mechanism and drug treatment mechanism of depression. Curr Neuropharmacol 13: 514-523. https://doi.org/10.2174/1570159x1304150831120428 ![]() |
[280] |
Johannsen A, Rylander G, Soder B, et al. (2006) Dental plaque, gingival inflammation, and elevated levels of interleukin-6 and cortisol in gingival crevicular fluid from women with stress-related depression and exhaustion. J Periodontol 77: 1403-1409. https://doi.org/10.1902/jop.2006.050411 ![]() |
[281] |
Duran-Pinedo AE, Solbiati J, Frias-Lopez J (2018) The effect of the stress hormone cortisol on the metatranscriptome of the oral microbiome. Npj Biofilms Microbiomes 4: 25. https://doi.org/10.1038/s41522-018-0068-z ![]() |
[282] |
Wingfield B, Lapsley C, McDowell A, et al. (2021) Variations in the oral microbiome are associated with depression in young adults. Sci Rep 11: 15009. https://doi.org/10.1038/s41598-021-94498-6 ![]() |
[283] |
Al Bataineh MT, Künstner A, Dash NR, et al. (2022) Altered composition of the oral microbiota in depression among cigarette smokers: A pilot study. Front Psychiatry 13: 902433. https://doi.org/10.3389/fpsyt.2022.902433 ![]() |
[284] |
Li C, Chen Y, Wen Y, et al. (2022) A genetic association study reveals the relationship between the oral microbiome and anxiety and depression symptoms. Front Psychiatry 13: 960756. https://doi.org/10.3389/fpsyt.2022.960756 ![]() |
[285] |
Alotiby A (2024) Immunology of stress: A review article. J Clin Med 13: 6394. https://doi.org/10.3390/jcm13216394 ![]() |
[286] |
Paudel D, Uehara O, Giri S, et al. (2022) Effect of psychological stress on the oral-gut microbiota and the potential oral-gut-brain axis. Jpn Dent Sci Rev 58: 365-375. https://doi.org/10.1016/j.jdsr.2022.11.003 ![]() |
[287] | Yaribeygi H, Panahi Y, Sahraei H, et al. (2017) The impact of stress on body function: A review. EXCLI J 16: 1057-1072. https://doi.org/10.17179/excli2017-480 |
[288] |
Sonnenburg JL, Sonnenburg ED (2019) Vulnerability of the industrialized microbiota. Science 366: eaaw9255. https://doi.org/10.1126/science.aaw9255 ![]() |
[289] |
Godoy LD, Rossignoli MT, Delfino-Pereira P, et al. (2018) A comprehensive overview on stress neurobiology: Basic concepts and clinical implications. Front Behav Neurosci 12: 127. https://doi.org/10.3389/fnbeh.2018.00127 ![]() |
[290] |
Cain DW, Cidlowski JA (2017) Immune regulation by glucocorticoids. Nat Rev Immunol 17: 233-247. https://doi.org/10.1038/nri.2017.1 ![]() |
[291] |
Weinstein LI, Revuelta A, Pando RH (2015) Catecholamines and acetylcholine are key regulators of the interaction between microbes and the immune system. Ann N Y Acad Sci 1351: 39-51. https://doi.org/10.1111/nyas.12792 ![]() |
[292] |
Herman JP, McKlveen JM, Ghosal S, et al. (2016) Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol 6: 603-621. https://doi.org/10.1002/cphy.c150015 ![]() |
[293] |
Agorastos A, Chrousos GP (2022) The neuroendocrinology of stress: The stress-related continuum of chronic disease development. Mol Psychiatry 27: 502-513. https://doi.org/10.1038/s41380-021-01224-9 ![]() |
[294] |
Elenkov IJ (2002) Systemic stress-induced Th2 shift and its clinical implications. Int Rev Neurobiol 52: 163-186. https://doi.org/10.1016/s0074-7742(02)52009-2 ![]() |
[295] |
Par M, Tarle Z (2019) Psychoneuroimmunology of oral diseases-A review. Stomatol Edu J 6: 55-65. https://doi.org/10.25241/stomaeduj.2019.6(1).art.7 ![]() |
[296] |
Ganesan A, Kumar G, Gauthaman J, et al. (2024) Exploring the relationship between psychoneuroimmunology and oral diseases: A comprehensive review and analysis. J Lifestyle Med 14: 13-19. https://doi.org/10.15280/jlm.2024.14.1.13 ![]() |
[297] |
Engeland CG, Bosch JA, Rohleder N (2019) Salivary biomarkers in psychoneuroimmunology. Curr Opin Behav Sci 28: 58-65. https://doi.org/10.1016/j.cobeha.2019.01.007 ![]() |
[298] |
Zhang J, Lin S, Luo L, et al. (2023) Psychological stress: Neuroimmune roles in periodontal disease. Odontology 111: 554-564. https://doi.org/10.1007/s10266-022-00768-8 ![]() |
[299] |
Roberts A, Matthews JB, Socransky SS, et al. (2002) Stress and the periodontal diseases: Effects of catecholamines on the growth of periodontal bacteria in vitro. Oral Microbiol Immunol 17: 296-303. https://doi.org/10.1034/j.1399-302X.2002.170506.x ![]() |
[300] |
Calil CM, Oliveira GM, Cogo K, et al. (2014) Effects of stress hormones on the production of volatile sulfur compounds by periodontopathogenic bacteria. Braz Oral Res 28: S1806-83242014000100228. https://doi.org/10.1590/1807-3107bor-2014.vol28.0008 ![]() |
[301] |
de Lima PO, Nani BD, Almeida B, et al. (2018) Stress-related salivary proteins affect the production of volatile sulfur compounds by oral bacteria. Oral Dis 24: 1358-1366. https://doi.org/10.1111/odi.12890 ![]() |
[302] |
Nani BD, Lima PO, Marcondes FK, et al. (2017) Changes in salivary microbiota increase volatile sulfur compounds production in healthy male subjects with academic-related chronic stress. PLoS One 12: e0173686. https://doi.org/10.1371/journal.pone.0173686 ![]() |
[303] |
Kohn JN, Kosciolek T, Marotz C, et al. (2020) Differing salivary microbiome diversity, community and diurnal rhythmicity in association with affective state and peripheral inflammation in adults. Brain Behav Immun 87: 591-602. https://doi.org/10.1016/j.bbi.2020.02.004 ![]() |
[304] |
Levert-Levitt E, Shapira G, Sragovich S, et al. (2022) Oral microbiota signatures in post-traumatic stress disorder (PTSD) veterans. Mol Psychiatry 27: 4590-4598. https://doi.org/10.1038/s41380-022-01704-6 ![]() |
[305] |
Stoy S, McMillan A, Ericsson AC, et al. (2023) The effect of physical and psychological stress on the oral microbiome. Front Psychol 14: 1166168. https://doi.org/10.3389/fpsyg.2023.1166168 ![]() |
[306] |
Alex AM, Levendosky AA, Bogat GA, et al. (2024) Stress and mental health symptoms in early pregnancy are associated with the oral microbiome. BMJ Ment Health 27: e301100. https://doi.org/10.1136/bmjment-2024-301100 ![]() |
[307] |
Charalambous EG, Mériaux SB, Guebels P, et al. (2024) The oral microbiome is associated with HPA axis response to a psychosocial stressor. Sci Rep 14: 15841. https://doi.org/10.1038/s41598-024-66796-2 ![]() |
[308] |
Akcali A, Huck O, Tenenbaum H, et al. (2013) Periodontal diseases and stress: A brief review. J Oral Rehabil 40: 60-68. https://doi.org/10.1111/j.1365-2842.2012.02341.x ![]() |
[309] |
Kim HM, Rothenberger CM, Davey ME (2022) Cortisol promotes surface translocation of Porphyromonas gingivalis. Pathogens 11: 982. https://doi.org/10.3390/pathogens11090982 ![]() |
[310] |
Jentsch HF, März D, Krüger M (2013) The effects of stress hormones on growth of selected periodontitis related bacteria. Anaerobe 24: 49-54. https://doi.org/10.1016/j.anaerobe.2013.09.001 ![]() |
[311] |
Zhang Y, Chen R, Zhang D, et al. (2023) Metabolite interactions between host and microbiota during health and disease: Which feeds the other?. Biomed Pharmacother 160: 114295. https://doi.org/10.1016/j.biopha.2023.114295 ![]() |
[312] |
McIntyre RS, Calabrese JR (2019) Bipolar depression: The clinical characteristics and unmet needs of a complex disorder. Curr Med Res Opin 35: 1993-2005. https://doi.org/10.1080/03007995.2019.1636017 ![]() |
[313] |
Baek JH, Jung SJ, Peters A, et al. (2023) Association between periodontal diseases and bipolar disorder: Implications for therapeutic interventions: A narrative review. Precis Future Med 7: 117-122. https://doi.org/10.23838/pfm.2023.00086 ![]() |
[314] |
Cunha FA, Cota LOM, Cortelli SC, et al. (2018) Periodontal condition and levels of bacteria associated with periodontitis in individuals with bipolar affective disorders: A case-control study. J Periodontal Res 54: 63-72. https://doi.org/10.1111/jre.12605 ![]() |
[315] |
Stępnicki P, Kondej M, Kaczor AA (2018) Current concepts and treatments of schizophrenia. Molecules 23: 2087. https://doi.org/10.3390/molecules23082087 ![]() |
[316] |
Martin S, Foulon A, El Hage W, et al. (2022) Is there a link between oropharyngeal microbiome and schizophrenia? A narrative review. Int J Mol Sci 23: 846. https://doi.org/10.3390/ijms23020846 ![]() |
[317] |
Murray N, Al Khalaf S, Kaulmann D, et al. (2021) Compositional and functional alterations in the oral and gut microbiota in patients with psychosis or schizophrenia: A systematic review. HRB Open Res 4: 108. https://doi.org/10.12688/hrbopenres.13416.1 ![]() |
[318] |
Cui G, Qing Y, Li M, et al. (2021) Salivary metabolomics reveals that metabolic alterations precede the onset of schizophrenia. J Proteome Res 20: 5010-5023. https://doi.org/10.1021/acs.jproteome.1c00504 ![]() |
[319] |
Castro-Nallar E, Bendall ML, Pérez-Losada M, et al. (2015) Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls. PeerJ 3: e1140. https://doi.org/10.7717/peerj.1140 ![]() |
[320] |
Dickerson F, Severance E, Yolken R (2017) The microbiome, immunity, and schizophrenia and bipolar disorder. Brain Behav Immun 62: 46-52. https://doi.org/10.1016/j.bbi.2016.12.010 ![]() |
[321] |
Yolken R, Prandovszky E, Severance EG, et al. (2021) The oropharyngeal microbiome is altered in individuals with schizophrenia and mania. Schizophr Res 234: 51-57. https://doi.org/10.1016/j.schres.2020.03.010 ![]() |
[322] |
Qing Y, Xu L, Cui G, et al. (2021) Salivary microbiome profiling reveals a dysbiotic schizophrenia-associated microbiota. NPJ Schizophr 7: 51. https://doi.org/10.1038/s41537-021-00180-1 ![]() |
[323] |
Ling Z, Cheng Y, Liu X, et al. (2023) Altered oral microbiota and immune dysfunction in Chinese elderly patients with schizophrenia: A cross-sectional study. Transl Psychiatry 13: 383. https://doi.org/10.1038/s41398-023-02682-1 ![]() |
[324] |
Liu X, Ling Z, Cheng Y, et al. (2024) Oral fungal dysbiosis and systemic immune dysfunction in Chinese patients with schizophrenia. Transl Psychiatry 14: 475. https://doi.org/10.1038/s41398-024-03183-5 ![]() |
[325] |
Botero JE, Rodríguez-Medina C, Amaya-Sanchez S, et al. (2024) A comprehensive review of the relationship between oral health and Down syndrome. Curr Oral Health Rep 11: 15-22. https://doi.org/10.1007/s40496-024-00363-6 ![]() |
[326] | Reuland-Bosma W, Van der Reijden WA, VanWinkelhoff AJ (2001) Absence of a specific subgingival microflora in adults with Down's syndrome. J Clin Periodontol 28: 1004-1009. https://doi.org/10.1034/j.1600-051x.2001.281103.x |
[327] |
Amano A, Kishima T, Akiyama S, et al. (2001) Relationship of periodontopathic bacteria with early-onset periodontitis in Down's syndrome. J Periodontol 72: 368-373. https://doi.org/10.1902/jop.2001.72.3.368 ![]() |
[328] | Linossier AG, Valenzuela CY, Toledo H (2008) Differences of the oral colonization by Streptococcus of the mutans group in children and adolescents with Down syndrome, mental retardation and normal controls. Med Oral Patol Oral Cir Bucal 13: 536-539. |
[329] |
Khocht A, Yaskell T, Janal M (2012) Subgingival microbiota in adult down syndrome periodontitis. J Periodontal Res 47: 500-507. https://doi.org/10.1111/j.1600-0765.2011.01459.x ![]() |
[330] |
Willis JR, Iraola-Guzmán S, Saus E, et al. (2020) Oral microbiome in down syndrome and its implications on oral health. J Oral Microbiol 13: 1865690. https://doi.org/10.1080/20002297.2020.1865690 ![]() |
[331] |
Cuenca M, Marín MJ, Nóvoa L, et al. (2021) Periodontal condition and subgingival microbiota characterization in subjects with Down syndrome. Appl Sci 11: 778. https://doi.org/10.3390/app11020778 ![]() |
[332] |
Mitsuhata C, Kado N, Hamada M, et al. (2022) Characterization of the unique oral microbiome of children with Down syndrome. Sci Rep 12: 14150. https://doi.org/10.1038/s41598-022-18409-z ![]() |
[333] |
Contaldo M, Lucchese A, Romano A, et al. (2021) Oral microbiota features in subjects with Down syndrome and periodontal diseases: A systematic review. Int J Mol Sci 22: 9251. https://doi.org/10.3390/ijms22179251 ![]() |
[334] |
Nóvoa Garrido L, Sánchez MD, Blanco Carrión J, et al. (2020) The subgingival microbiome in patients with Down syndrome and periodontitis. J Clin Med 9: 2482. https://doi.org/10.3390/jcm9082482 ![]() |
[335] | Diéguez-Pérez M, de Nova-García MJ, Mourelle-Martínez MR, et al. (2016) Oral health in children with physical (Cerebral Palsy) and intellectual (Down Syndrome) disabilities: Systematic review I. J Clin Exp Dent 8: e337-e343. https://doi.org/10.4317/jced.52922 |
[336] |
Sinha N, Singh B, Chhabra KG, et al. (2015) Comparison of oral health status between children with cerebral palsy and normal children in India: A case-control study. J Indian Soc Periodontol 19: 78-82. https://doi.org/10.4103/0972-124X.145800 ![]() |
[337] |
Huang C, Chu C, Peng Y, et al. (2022) Correlations between gastrointestinal and oral microbiota in children with cerebral palsy and epilepsy. Front Pediatr 10: 988601. https://doi.org/10.3389/fped.2022.988601 ![]() |
[338] |
Liu M, Shi Y, Wu K, et al. (2022) From mouth to brain: Distinct supragingival plaque microbiota composition in cerebral palsy children with caries. Front Cell Infect Microbiol 12: 814473. https://doi.org/10.3389/fcimb.2022.814473 ![]() |
[339] |
Lian X, Liu Z, Wu T, et al. (2023) Oral microbiome alterations in epilepsy and after seizure control. Front Microbiol 14: 1277022. https://doi.org/10.3389/fmicb.2023.1277022 ![]() |
[340] |
Zhao C, Chen F, Li Q, et al. (2024) Causal relationship between oral microbiota and epilepsy risk: Evidence from Mendelian randomization analysis in East Asians. Epilepsia Open 9: 2419-2428. https://doi.org/10.1002/epi4.13074 ![]() |
[341] | World Health OrganizationOral health (2024). Available online: https://Www.Who.Int/Health-Topics/Oral-Health/#tab=tab_1 (accessed on 4 December 2024) |
[342] |
Varoni EM, Rimondini L (2022) Oral microbiome, oral health and systemic health: A multidirectional link. Biomedicines 10: 186. https://doi.org/10.3390/biomedicines10010186 ![]() |
[343] |
Militi A, Sicari F, Portelli M, et al. (2021) Psychological and social effects of oral health and dental aesthetic in adolescence and early adulthood: An observational study. Int J Environ Res Public Health 18: 9022. https://doi.org/10.3390/ijerph18179022 ![]() |
[344] |
Ferreira MC, Dias-Pereira AC, Branco-de-Almeida LS, et al. (2017) Impact of periodontal disease on quality of life: A systematic review. J Periodontal Res 52: 651-665. https://doi.org/10.1111/jre.12436 ![]() |
[345] |
Kastenbom L, Falsen A, Larsson P, et al. (2019) Costs and health-related quality of life in relation to caries. BMC Oral Health 19: 187. https://doi.org/10.1186/s12903-019-0874-6 ![]() |
[346] |
Yuwanati M, Gondivkar S, Sarode SC, et al. (2021) Oral health-related quality of life in oral cancer patients: Systematic review and meta-analysis. Future Oncol 17: 979-990. https://doi.org/10.2217/fon-2020-0881 ![]() |
[347] |
Wensel CR, Pluznick JL, Salzberg SL, et al. (2022) Next-generation sequencing: Insights to advance clinical investigations of the microbiome. J Clinical Invest 132: e154944. https://doi.org/10.1172/JCI154944 ![]() |
[348] |
Nomura Y, Inai Y, Okada A, et al. (2023) Oral microbiome and oral health: Current stage and future prospective. Appl Sci 13: 11372. https://doi.org/10.3390/app132011372 ![]() |
[349] | Chi L, Cheng X, Lin L, et al. (2021) Porphyromonas gingivalis-induced cognitive impairment is associated with gut dysbiosis, neuroinflammation, and glymphatic dysfunction. Front Cell Infect Microbiol 11: 977. https://doi.org/10.3389/fcimb.2021.755925 |
[350] |
Simas AM, Kramer CD, Weinberg EO, et al. (2021) Oral infection with a periodontal pathogen alters oral and gut microbiomes. Anaerobe 71: 102399. https://doi.org/10.1016/j.anaerobe.2021.102399 ![]() |
[351] |
Kato T, Yamazaki K, Nakajima M, et al. (2018) Oral administration of Porphyromonas gingivalis alters the gut microbiome and serum metabolome. mSphere 3: e00460-18. https://doi.org/10.1128/mSphere.00460-18 ![]() |
[352] |
Leblhuber F, Ehrlich D, Steiner K, et al. (2021) The immunopathogenesis of Alzheimer's disease is related to the composition of gut microbiota. Nutrients 13: 361. https://doi.org/10.3390/nu13020361 ![]() |
[353] |
Preshaw PM (2018) Host modulation therapy with anti-inflammatory agents. Periodontology 2000 76: 131-149. https://doi.org/10.1111/prd.12148 ![]() |
[354] |
Yurko-Mauro K, McCarthy D, Rom D, et al. (2010) Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement 6: 456-464. https://doi.org/10.1016/j.jalz.2010.01.013 ![]() |
[355] |
Borrego-Ruiz A, González-Domenech CM, Borrego JJ (2024) The role of fermented vegetables as a sustainable and health-promoting nutritional resource. Appl Sci 14: 10853. https://doi.org/10.3390/app142310853 ![]() |
[356] |
Ribeiro-Vidal H, Sánchez MC, Alonso-Español A, et al. (2020) Antimicrobial activity of EPA and DHA against oral pathogenic bacteria using an in vitro multi-species subgingival biofilm model. Nutrients 12: 2812. https://doi.org/10.3390/nu12092812 ![]() |
[357] |
Khalifa K, Bergland AK, Soennesyn H, et al. (2020) Effects of purified anthocyanins in people at risk for dementia: Study protocol for a phase II randomized controlled trial. Front Neurol 11: 916. https://doi.org/10.3389/fneur.2020.00916 ![]() |
[358] |
Ullah R, Khan M, Shah SA, et al. (2019) Natural antioxidant anthocyanins - A hidden therapeutic candidate in metabolic disorders with major focus in neurodegeneration. Nutrients 11: 1195. https://doi.org/10.3390/nu11061195 ![]() |
[359] |
Guo Y, Li Z, Chen F, et al. (2023) Polyphenols in oral health: Homeostasis maintenance, disease prevention, and therapeutic applications. Nutrients 15: 4384. https://doi.org/10.3390/nu15204384 ![]() |
[360] |
Kovac J, Slobodnikova L, Trajcikova E, et al. (2022) Therapeutic potential of flavonoids and tannins in management of oral infectious diseases - A review. Molecules 28: 158. https://doi.org/10.3390/molecules28010158 ![]() |
[361] |
Gorr SU, Abdolhosseini M (2011) Antimicrobial peptides and periodontal disease. J Clin Periodontol 38: 126-141. https://doi.org/10.1111/j.1600-051X.2010.01664.x ![]() |
[362] |
Luo SC, Wei SM, Luo XT, et al. (2024) How probiotics, prebiotics, synbiotics, and postbiotics prevent dental caries: An oral microbiota perspective. NP J Biofilms Microbiomes 10: 14. https://doi.org/10.1038/s41522-024-00488-7 ![]() |
[363] |
Suresh N, Joseph B, Sathyan P, et al. (2024) Photodynamic therapy: An emerging therapeutic modality in dentistry. Bioorg Med Chem 114: 117962. https://doi.org/10.1016/j.bmc.2024.117962 ![]() |
[364] |
Wright PP, Ramachandra SS (2022) Quorum sensing and quorum quenching with a focus on cariogenic and periodontopathic oral biofilms. Microorganisms 10: 1783. https://doi.org/10.3390/microorganisms10091783 ![]() |
[365] |
Guo X, Wang X, Shi J, et al. (2024) A review and new perspective on oral bacteriophages: Manifestations in the ecology of oral diseases. J Oral Microbiol 16: 2344272. https://doi.org/10.1080/20002297.2024.2344272 ![]() |
[366] |
Maitre Y, Mahalli R, Micheneau P, et al. (2021) Pre and probiotics involved in the modulation of oral bacterial species: New therapeutic leads in mental disorders?. Microorganisms 9: 1450. https://doi.org/10.3390/microorganisms9071450 ![]() |
[367] | Borrego-Ruiz A, Borrego JJ (2024) Pychobiotics: A new perspective on the treatment of stress, anxiety, and depression. Anxiety Stress 30: 79-93. https://doi.org/10.5093/anyes2024a11 |
[368] |
Borrego-Ruiz A, Borrego JJ (2024) Microbial dysbiosis in the skin microbiome and its psychological consequences. Microorganisms 12: 1908. https://doi.org/10.3390/microorganisms12091908 ![]() |
Factors | Major findings | Reference |
Health conditions | Poor: -Lower microbial diversity -Increases abundance of Aggregatibacter segnis, Achromobacter xylosoxidans, and Neisseria cluster II Good: -Increases abundance of Megasphaera micronuciformis, Veillonella atypica, V. parvula, Rothia mucilaginosa, Prevotella histicola, Fusobacterium nucleatum, Granulicatella adiacens, and Tannerella forsythia |
[75],[76] |
Antibiotic treatment | -Decreases Actinomycetota members | [76],[77] |
-Reduces diversity index -Decreases abundance of Actinomycetota, Bacteroidota, and Fusobacteriota members -Increases abundance of members of Pseudomonadota and Aggregatibacter aphrophilus |
||
-Decreases the abundance of Neisseria, Streptococcus, and Veillonella and of members of Rikenellaceae | [78]–[80] | |
-Increases antibiotic-resistant genes | [81] | |
Dietary patterns | -Higher proportion of Streptococcus in breastfed infants -Increases abundance of Actinomyces and Prevotella in formula-fed infants |
[82] |
-Positive correlation between carbonated beverages and the abundance of Bacteroidota, Pseudomonadota, Fusobacterium, and Veillonella | [83] | |
-Alcohol consumption increases Streptococcus mutans and inhibits Fusobacterium activity | [84] | |
Smoking | -Decreases abundance of Streptococcus sanguinis and S. parasanguinis -Increases abundance of Fusobacterium naviforme and F. nucleatum |
[85] |
Smoking | -Decreases abundance of Pseudomonadota, Neisseria subflava, Corynebacterium, Capnocytophaga, Peptostreptococcus, and Leptotrichia -Increases abundance of Bacillota, Actinomycetota, Atopobium and Streptococcus |
[86] |
-Increases microbial diversity -Increases abundance of Fusobacteriota, Actinomycetota, Streptococcus, Prevotella, and Veillonella |
[87] | |
Pregnancy | -Increases abundance of Neisseria, Porphyromonas, and Treponema -Decreases abundance of Streptococcus and Veillonella |
[88] |
-Increases abundance of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans | [89] |
Phylum | Genera | Systemic diseases | Reference |
Bacillota | Lactobacillus | Cardiovascular | [144] |
Selenomonas | Systemic lupus erithematosus Lung cancer |
[145],[146] | |
Solobacterium | Bacteremia | [147] | |
Streptococcus | Diabetes Cardiovascular Chronic obstructive pulmonary Colorectal cancer |
[144],[148]–[150] | |
Veillonella | Hirschsprung's disease-associated enterocolitis Cardiovascular Lung cancer Inflammatory bowel disease |
[146],[151]–[153] | |
Bacteroidota | Capnocytophaga | Diabetes Lung cancer |
[146],[154] |
Bacteroidota | Porphyromonas | Diabetes Cardiovascular Rheumatoid arthritis Adverse pregnancy outcomes Inflammatory bowel disease Pancreatic cancer Esophageal cancer |
[155]–[162] |
Prevotella | Metabolic dysfunction Cardiovascular Rheumatoid arthritis Inflammatory bowel disease Systemic lupus erithematosus |
[151],[163]–[166] | |
Tannerella | Diabetes Cardiovascular Rheumatoid arthritis Esophageal cancer |
[160],[167]–[169] | |
Fusobacteriota | Fusobacterium | Diabetes Cardiovascular Chronic obstructive pulmonary Adverse pregnancy outcomes Ulcerative colitis Colorectal cancer |
[170]–[175] |
Pseudomonadota | Aggregatibacter | Diabetes Cardiovascular Inflammatory bowel disease Pancreatic cancer |
[176]–[180] |
Campylobacter | Inflammatory bowel disease | [181] | |
Haemophilus | Chronic obstructive pulmonary | [182] | |
Moraxella | Chronic obstructive pulmonary | [183] | |
Spirochaetota | Treponella | Diabetes | [169] |
Factors | Major findings | Reference |
Health conditions | Poor: -Lower microbial diversity -Increases abundance of Aggregatibacter segnis, Achromobacter xylosoxidans, and Neisseria cluster II Good: -Increases abundance of Megasphaera micronuciformis, Veillonella atypica, V. parvula, Rothia mucilaginosa, Prevotella histicola, Fusobacterium nucleatum, Granulicatella adiacens, and Tannerella forsythia |
[75],[76] |
Antibiotic treatment | -Decreases Actinomycetota members | [76],[77] |
-Reduces diversity index -Decreases abundance of Actinomycetota, Bacteroidota, and Fusobacteriota members -Increases abundance of members of Pseudomonadota and Aggregatibacter aphrophilus |
||
-Decreases the abundance of Neisseria, Streptococcus, and Veillonella and of members of Rikenellaceae | [78]–[80] | |
-Increases antibiotic-resistant genes | [81] | |
Dietary patterns | -Higher proportion of Streptococcus in breastfed infants -Increases abundance of Actinomyces and Prevotella in formula-fed infants |
[82] |
-Positive correlation between carbonated beverages and the abundance of Bacteroidota, Pseudomonadota, Fusobacterium, and Veillonella | [83] | |
-Alcohol consumption increases Streptococcus mutans and inhibits Fusobacterium activity | [84] | |
Smoking | -Decreases abundance of Streptococcus sanguinis and S. parasanguinis -Increases abundance of Fusobacterium naviforme and F. nucleatum |
[85] |
Smoking | -Decreases abundance of Pseudomonadota, Neisseria subflava, Corynebacterium, Capnocytophaga, Peptostreptococcus, and Leptotrichia -Increases abundance of Bacillota, Actinomycetota, Atopobium and Streptococcus |
[86] |
-Increases microbial diversity -Increases abundance of Fusobacteriota, Actinomycetota, Streptococcus, Prevotella, and Veillonella |
[87] | |
Pregnancy | -Increases abundance of Neisseria, Porphyromonas, and Treponema -Decreases abundance of Streptococcus and Veillonella |
[88] |
-Increases abundance of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans | [89] |
Phylum | Genera | Systemic diseases | Reference |
Bacillota | Lactobacillus | Cardiovascular | [144] |
Selenomonas | Systemic lupus erithematosus Lung cancer |
[145],[146] | |
Solobacterium | Bacteremia | [147] | |
Streptococcus | Diabetes Cardiovascular Chronic obstructive pulmonary Colorectal cancer |
[144],[148]–[150] | |
Veillonella | Hirschsprung's disease-associated enterocolitis Cardiovascular Lung cancer Inflammatory bowel disease |
[146],[151]–[153] | |
Bacteroidota | Capnocytophaga | Diabetes Lung cancer |
[146],[154] |
Bacteroidota | Porphyromonas | Diabetes Cardiovascular Rheumatoid arthritis Adverse pregnancy outcomes Inflammatory bowel disease Pancreatic cancer Esophageal cancer |
[155]–[162] |
Prevotella | Metabolic dysfunction Cardiovascular Rheumatoid arthritis Inflammatory bowel disease Systemic lupus erithematosus |
[151],[163]–[166] | |
Tannerella | Diabetes Cardiovascular Rheumatoid arthritis Esophageal cancer |
[160],[167]–[169] | |
Fusobacteriota | Fusobacterium | Diabetes Cardiovascular Chronic obstructive pulmonary Adverse pregnancy outcomes Ulcerative colitis Colorectal cancer |
[170]–[175] |
Pseudomonadota | Aggregatibacter | Diabetes Cardiovascular Inflammatory bowel disease Pancreatic cancer |
[176]–[180] |
Campylobacter | Inflammatory bowel disease | [181] | |
Haemophilus | Chronic obstructive pulmonary | [182] | |
Moraxella | Chronic obstructive pulmonary | [183] | |
Spirochaetota | Treponella | Diabetes | [169] |